<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Diabetol Metab Syndr</journal-id><journal-id journal-id-type="iso-abbrev">Diabetol Metab Syndr</journal-id><journal-id journal-id-type="pmc-domain-id">964</journal-id><journal-id journal-id-type="pmc-domain">diametsyn</journal-id><journal-title-group><journal-title>Diabetology &amp; Metabolic Syndrome</journal-title></journal-title-group><issn pub-type="epub">1758-5996</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12181894</article-id><article-id pub-id-type="pmcid-ver">PMC12181894.1</article-id><article-id pub-id-type="pmcaid">12181894</article-id><article-id pub-id-type="pmcaiid">12181894</article-id><article-id pub-id-type="pmid">40544266</article-id><article-id pub-id-type="doi">10.1186/s13098-025-01795-5</article-id><article-id pub-id-type="publisher-id">1795</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Predictive value of obesity-related indices for incident type 2 diabetes mellitus: a longitudinal study of the Fukushima Health Database 2015&#8211;2021</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Ma</surname><given-names initials="E">Enbo</given-names></name><address><email>mae@fmu.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ohira</surname><given-names initials="T">Tetsuya</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fukasawa</surname><given-names initials="M">Maiko</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shirafuji</surname><given-names initials="A">Atsushi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Matsuzaki</surname><given-names initials="K">Kenta</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hosoya</surname><given-names initials="M">Mitsuaki</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yasumura</surname><given-names initials="S">Seiji</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shimabukuro</surname><given-names initials="M">Michio</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/012eh0r35</institution-id><institution-id institution-id-type="GRID">grid.411582.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 1017 9540</institution-id><institution>Health Promotion Center, </institution><institution>Fukushima Medical University, </institution></institution-wrap>1 Hikariga-Oka, Fukushima, 960-1295 Japan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/012eh0r35</institution-id><institution-id institution-id-type="GRID">grid.411582.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 1017 9540</institution-id><institution>Department of Epidemiology, </institution><institution>Fukushima Medical University School of Medicine, </institution></institution-wrap>Fukushima, 960-1295 Japan </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/012eh0r35</institution-id><institution-id institution-id-type="GRID">grid.411582.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 1017 9540</institution-id><institution>Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, </institution></institution-wrap>Fukushima, 960-1295 Japan </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02pg0e883</institution-id><institution-id institution-id-type="GRID">grid.265880.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1763 0236</institution-id><institution>Department of Computer Science and Engineering, </institution><institution>The University of Aizu, </institution></institution-wrap>Fukushima, 965-8580 Japan </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/012eh0r35</institution-id><institution-id institution-id-type="GRID">grid.411582.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 1017 9540</institution-id><institution>Department of Diabetes, Endocrinology and Metabolism, </institution><institution>Fukushima Medical University School of Medicine, </institution></institution-wrap>Fukushima, 960-1295 Japan </aff></contrib-group><pub-date pub-type="epub"><day>21</day><month>6</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>17</volume><issue-id pub-id-type="pmc-issue-id">478402</issue-id><elocation-id>236</elocation-id><history><date date-type="received"><day>18</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>2</day><month>6</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>21</day><month>06</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>21</day><month>06</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-06-23 13:25:18.483"><day>23</day><month>06</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="13098_2025_Article_1795.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Obesity indices that combine anthropometric and lipid measurements, such as the atherogenic index of plasma (AIP), cardiometabolic index (CMI), lipid accumulation product (LAP), metabolic score for insulin resistance (Mets-IR), triglyceride-glucose (TyG) index, and visceral adiposity index (VAI), have been recommended as surrogates for assessing cardiometabolic risk. This study aimed to examine the association between these indices and type 2 diabetes mellitus (T2DM) incidence risk using large routine health checkup data. </p></sec><sec><title>Methods</title><p id="Par2">This retrospective cohort study involved 195,989 participants aged 35&#8211;74 years who attended the Specific Health Checkups in 2015 and were observed until 2021 in Fukushima, Japan. We used multivariable Cox regression analysis to examine the associations between the indices and T2DM risk and evaluated the diagnostic utility of the indices.</p></sec><sec><title>Results</title><p id="Par3">The accumulated T2DM incidence rate per 100,000 person-years over a mean follow-up of 4.61 years was 706.6 in males and 441.2 in females. Multiple adjusted hazard ratios were significantly higher in the highest quartile of indices (1.33&#8211;4.22 fold higher) compared to the lowest quartile. The increased risk in the higher quartiles was more pronounced in participants aged&#8201;&lt;&#8201;50 years than in those aged&#8201;&#8805;&#8201;50 years for both sexes. The areas under the receiver operating characteristic curves (AUC) of AIP, CMI, LAP, and VAI were between 0.821 and 0.844, whereas those of Mets-IR and TyG were between 0.756 and 0.780. For both sexes, AUCs for AIP, CMI, and LAP showed no significant differences (<italic toggle="yes">P</italic> values&#8201;&gt;&#8201;0.05), but other pairwise indices had significant differences (<italic toggle="yes">P</italic> values&#8201;&lt;&#8201;0.001). AUCs were higher in participants with a body mass index (BMI) of&#8201;&lt;&#8201;25 kg/m<sup>2</sup> or aged&#8201;&lt;&#8201;50 years than in those with a BMI&#8201;&#8805;&#8201;25 kg/m<sup>2</sup> or aged&#8201;&#8805;&#8201;50 years, respectively. Net reclassification improvements of models for CMI and LAP were similar to AIP, while those for Mets-IR, TyG, and VAI were significantly lower than AIP.</p></sec><sec><title>Conclusions</title><p id="Par4">Obesity indices are positively associated with and applicable for predicting new-onset T2DM in Japanese adults, particularly AIP, CMI, and LAP.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s13098-025-01795-5.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Type 2 diabetes mellitus</kwd><kwd>Obesity indices</kwd><kwd>AIP</kwd><kwd>CMI</kwd><kwd>LAP</kwd><kwd>Mets-IR</kwd><kwd>TyG</kwd><kwd>VAI</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par24">Type 2 diabetes mellitus (T2DM), a multifaceted and interrelated disease, is characterized by insulin resistance and is causally associated with weight gain and hyperglycemia [<xref ref-type="bibr" rid="CR1">1</xref>]. To prevent T2DM, lifestyle interventions may be more effective than drug treatments [<xref ref-type="bibr" rid="CR2">2</xref>], in which achieving and maintaining optimal body weight is essential [<xref ref-type="bibr" rid="CR3">3</xref>].</p><p id="Par25">Body mass index (BMI) is a common measurement parameter for general obesity, while waist circumference (WC), waist-to-height ratio, and waist-to-hip ratio are better than BMI in characterizing central or abdominal obesity [<xref ref-type="bibr" rid="CR4">4</xref>]. Elevated fasting glucose levels indicate impaired glucose regulation and may serve as an early indicator of insulin resistance and diabetes onset [<xref ref-type="bibr" rid="CR5">5</xref>]; however, its efficacy compared to other indices for detecting diabetes needs to be validated [<xref ref-type="bibr" rid="CR6">6</xref>]. Blood-based single lipid measurements of low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), total lipoprotein cholesterol, and triglyceride (TG) vary in their ability to predict T2DM risk.</p><p id="Par26">Body fat is more accurately measured by computer tomography, dual-energy x-ray absorptiometry, and bioelectrical impedance analysis for visceral adipose tissue [<xref ref-type="bibr" rid="CR7">7</xref>&#8211;<xref ref-type="bibr" rid="CR9">9</xref>] or body fat percentage [<xref ref-type="bibr" rid="CR10">10</xref>&#8211;<xref ref-type="bibr" rid="CR12">12</xref>]; however, these methods are inconvenient and expensive. Several novel nontraditional anthropometric indices and lipid parameters have been recommended as cost-effective surrogate markers of visceral fat measurements, such as obesity-related atherogenic index of plasma (AIP) [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>], cardiometabolic index (CMI) [<xref ref-type="bibr" rid="CR15">15</xref>], lipid accumulation product (LAP) [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR14">14</xref>&#8211;<xref ref-type="bibr" rid="CR22">22</xref>], the metabolic score for insulin resistance (Mets-IR) [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR23">23</xref>], triglyceride-glucose (TyG) index [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR24">24</xref>&#8211;<xref ref-type="bibr" rid="CR26">26</xref>], and body fat distribution related visceral adiposity index (VAI) [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR20">20</xref>&#8211;<xref ref-type="bibr" rid="CR22">22</xref>]. These cross-sectional and cohort studies have reported optimal results on the associations between markers and the risk of metabolic syndrome or T2DM. Studies in this area have been conducted in the Japanese general population, including an early study of LAP in young workers [<xref ref-type="bibr" rid="CR27">27</xref>], and more recent retrospective cohort studies on LAP [<xref ref-type="bibr" rid="CR28">28</xref>], Mets-IR [<xref ref-type="bibr" rid="CR29">29</xref>], and TyG [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>].</p><p id="Par27">In 2008, the Japanese government issued a health policy that included detailed annual health checkups and specific counselling (health promotion guidance) for all beneficiaries, targeting individuals at risk of metabolic syndrome [<xref ref-type="bibr" rid="CR32">32</xref>]. The annual basic health checkup incorporates routine clinically measured anthropometric and lipid parameters that may identify T2DM at an early stage. This study addressed gaps in obesity-related indices from Japanese insurance data. It examined their associations with T2DM incidence and predictive capability using health checkup data, informing T2DM prediction tools.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Study population</title><p id="Par28">The Fukushima Health Database (FDB) includes data from annual health checkups and health insurance claims of the National Health Insurance, part of the Employee Health Insurance (the Kyoukai Kenpo) for employees of small-to-medium-sized enterprises, and other insurances. Health insurance coverage in Fukushima Prefecture in 2015 was&#8201;&gt;&#8201;70% [<xref ref-type="bibr" rid="CR33">33</xref>].</p><p id="Par29">This study extracted data from 313,623 residents aged 35&#8211;74 years who attended health checkups in 2015 (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>). According to the 2015 prefecture census and a 48.2% health checkup implementation rate among individuals aged 40&#8211;74 years in 2016 [<xref ref-type="bibr" rid="CR33">33</xref>], the study participants accounted for&#8201;&gt;&#8201;66% of the Fukushima population aged 35&#8211;74 years who attend annual health checkups. After excluding patients with diagnosed T2DM, using insulin or oral medication for control of T2DM, a history of stroke, heart disease, or renal disease reported in 2015, as well as those who did not attend health checkups or whose claims data for 2016 and 2021 were unavailable, 195,989 participants were included in the analysis.<fig id="Fig1" position="float" orientation="portrait"><label>Fig.&#160;1</label><caption><p>Data flow for analysis, the Fukushima Health Database 2015&#8211;2021</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="13098_2025_1795_Fig1_HTML.jpg"/></fig></p><p id="Par30">The study was approved by the Fukushima Medical University Ethical Review Committee (Generic 2021&#8211;169). The study was conducted using secondary administrative data accumulated in the database, with personal information anonymised. Thus, informed consent was not obtained from participants.</p></sec><sec id="Sec4"><title>Demographic and lifestyle factors</title><p id="Par31">Demographic data included age and sex. The self-administered questionnaires included questions on medical history, alcohol consumption, smoking status, physical activity, and dietary habits and behavior.</p></sec><sec id="Sec5"><title>Clinical examinations</title><p id="Par32">Measurements of BMI (kg/m<sup>2</sup>, defined as body weight divided by height squared), waist circumference (cm), systolic blood pressure (SBP, mmHg), and diastolic blood pressure (DBP, mmHg) were recorded. Height was measured in stocking feet, and weight was measured in light indoor clothing. The waist circumference was measured using a tape measure wrapped around the waist in line with the navel at the minimum respiration. Blood pressure was measured with a standard sphygmomanometer or an automated device by medical staff at each local institute. Blood samples were collected from each participant after an eight-hour or more fasting period to measure the fasting plasma glucose (FPG) (mg/dL), low-density lipoprotein cholesterol (LDL-C; mg/dL), high-density lipoprotein cholesterol (HDL-C; mg/dL), and triglyceride (mg/dL) levels. Based on these measurements, the following obesity indices were calculated, converting the units from mg/dL to mmol/L when necessary.<table-wrap id="Taba" position="float" orientation="portrait"><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">AIP</th><th align="left" colspan="1" rowspan="1"><inline-formula id="IEq1"><alternatives><tex-math id="d33e536">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text{log}\left(\frac{\text{TG}(\text{mmol}/\text{L}}{\text{HDL}-\text{C}(\text{mmol}/\text{L}}\right)$$\end{document}</tex-math><mml:math id="d33e541"><mml:mrow><mml:mtext>log</mml:mtext><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mtext>TG</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>mmol</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:mtext>L</mml:mtext></mml:mrow><mml:mrow><mml:mtext>HDL</mml:mtext><mml:mo>-</mml:mo><mml:mtext>C</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>mmol</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:mtext>L</mml:mtext></mml:mrow></mml:mfrac></mml:mfenced></mml:mrow></mml:math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13098_2025_1795_Article_IEq1.gif"/></alternatives></inline-formula></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">CMI</td><td align="left" colspan="1" rowspan="1"><inline-formula id="IEq2"><alternatives><tex-math id="d33e571">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\frac{\text{TG}(\text{mmol}/\text{L})}{\text{HDL}-\text{C}(\text{mmol}/\text{L})}\times \frac{\text{WC}(\text{cm})}{\text{Height}(\text{cm})}$$\end{document}</tex-math><mml:math id="d33e576"><mml:mrow><mml:mfrac><mml:mrow><mml:mtext>TG</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>mmol</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:mtext>L</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mtext>HDL</mml:mtext><mml:mo>-</mml:mo><mml:mtext>C</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>mmol</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:mtext>L</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac><mml:mo>&#215;</mml:mo><mml:mfrac><mml:mrow><mml:mtext>WC</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>cm</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mtext>Height</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>cm</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13098_2025_1795_Article_IEq2.gif"/></alternatives></inline-formula></td></tr><tr><td align="left" colspan="1" rowspan="1">LAP</td><td align="left" colspan="1" rowspan="1"><p>(<inline-formula id="IEq3"><alternatives><tex-math id="d33e624">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text{WC}(\text{cm})-65)\times \text{TG}(\text{mmol}/\text{L})$$\end{document}</tex-math><mml:math id="d33e629"><mml:mrow><mml:mtext>WC</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>cm</mml:mtext><mml:mo stretchy="false">)</mml:mo><mml:mo>-</mml:mo><mml:mn>65</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo>&#215;</mml:mo><mml:mtext>TG</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>mmol</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:mtext>L</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13098_2025_1795_Article_IEq3.gif"/></alternatives></inline-formula> for man</p><p>(<inline-formula id="IEq4"><alternatives><tex-math id="d33e656">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text{WC}(\text{cm})-58)\times \text{TG}(\text{mmol}/\text{L})$$\end{document}</tex-math><mml:math id="d33e661"><mml:mrow><mml:mtext>WC</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>cm</mml:mtext><mml:mo stretchy="false">)</mml:mo><mml:mo>-</mml:mo><mml:mn>58</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo>&#215;</mml:mo><mml:mtext>TG</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>mmol</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:mtext>L</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13098_2025_1795_Article_IEq4.gif"/></alternatives></inline-formula> for woman</p></td></tr><tr><td align="left" colspan="1" rowspan="1">Mets-IR</td><td align="left" colspan="1" rowspan="1"><inline-formula id="IEq5"><alternatives><tex-math id="d33e691">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text{log}\left(2\times \text{FPG}(\text{mg}/\text{dL})+\text{TG}(\text{mg}/\text{dL}\right))\times \text{BMI}(\text{kg}/{\text{m}}^{2})\div \text{log}\left(\text{HDL}-\text{C}(\text{mg}/\text{dL})\right)$$\end{document}</tex-math><mml:math id="d33e696"><mml:mrow><mml:mtext>log</mml:mtext><mml:mfenced close=")" open="("><mml:mn>2</mml:mn><mml:mo>&#215;</mml:mo><mml:mtext>FPG</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>mg</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:mtext>dL</mml:mtext><mml:mo stretchy="false">)</mml:mo><mml:mo>+</mml:mo><mml:mtext>TG</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>mg</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:mtext>dL</mml:mtext></mml:mfenced><mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>&#215;</mml:mo><mml:mtext>BMI</mml:mtext></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mtext>kg</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:msup><mml:mrow><mml:mtext>m</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>&#247;</mml:mo><mml:mtext>log</mml:mtext><mml:mfenced close=")" open="("><mml:mtext>HDL</mml:mtext><mml:mo>-</mml:mo><mml:mtext>C</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>mg</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:mtext>dL</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mfenced></mml:mrow></mml:math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13098_2025_1795_Article_IEq5.gif"/></alternatives></inline-formula></td></tr><tr><td align="left" colspan="1" rowspan="1">TyG</td><td align="left" colspan="1" rowspan="1"><inline-formula id="IEq6"><alternatives><tex-math id="d33e757">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text{log}\left(0.5\times \text{FPG}(\text{mg}/\text{dL})\times \text{TG}(\text{mg}/\text{dL})\right)$$\end{document}</tex-math><mml:math id="d33e762"><mml:mrow><mml:mtext>log</mml:mtext><mml:mfenced close=")" open="("><mml:mn>0.5</mml:mn><mml:mo>&#215;</mml:mo><mml:mtext>FPG</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>mg</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:mtext>dL</mml:mtext><mml:mo stretchy="false">)</mml:mo><mml:mo>&#215;</mml:mo><mml:mtext>TG</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>mg</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:mtext>dL</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mfenced></mml:mrow></mml:math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13098_2025_1795_Article_IEq6.gif"/></alternatives></inline-formula></td></tr><tr><td align="left" colspan="1" rowspan="1">VAI</td><td align="left" colspan="1" rowspan="1"><p><inline-formula id="IEq7"><alternatives><tex-math id="d33e794">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\frac{\text{WC}(\text{cm})}{(39.68+1.88\times \text{BMI}(\text{kg}/{\text{m}}^{2})}\times \left(\frac{\text{TG}(\text{mmol}/\text{L})}{1.03}\right)\times \left(\frac{1.31}{\text{HDL}-\text{C}(\text{mmol}/\text{L})}\right),$$\end{document}</tex-math><mml:math id="d33e799"><mml:mrow><mml:mfrac><mml:mrow><mml:mtext>WC</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>cm</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>39.68</mml:mn><mml:mo>+</mml:mo><mml:mn>1.88</mml:mn><mml:mo>&#215;</mml:mo><mml:mtext>BMI</mml:mtext><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mtext>kg</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:msup><mml:mrow><mml:mtext>m</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>&#215;</mml:mo><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mtext>TG</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>mmol</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:mtext>L</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>1.03</mml:mn></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>&#215;</mml:mo><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mn>1.31</mml:mn></mml:mrow><mml:mrow><mml:mtext>HDL</mml:mtext><mml:mo>-</mml:mo><mml:mtext>C</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>mmol</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:mtext>L</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13098_2025_1795_Article_IEq7.gif"/></alternatives></inline-formula> for man</p><p><inline-formula id="IEq8"><alternatives><tex-math id="d33e865">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\frac{\text{WC}(\text{cm})}{(36.58+1.89\times \text{BMI}(\text{kg}/{\text{m}}^{2})}\times \left(\frac{\text{TG}(\text{mmol}/\text{L})}{0.81}\right)\times \left(\frac{1.52}{\text{HDL}-\text{C}(\text{mmol}/\text{L})}\right),$$\end{document}</tex-math><mml:math id="d33e870"><mml:mrow><mml:mfrac><mml:mrow><mml:mtext>WC</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>cm</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>36.58</mml:mn><mml:mo>+</mml:mo><mml:mn>1.89</mml:mn><mml:mo>&#215;</mml:mo><mml:mtext>BMI</mml:mtext><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mtext>kg</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:msup><mml:mrow><mml:mtext>m</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>&#215;</mml:mo><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mtext>TG</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>mmol</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:mtext>L</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>0.81</mml:mn></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>&#215;</mml:mo><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mn>1.52</mml:mn></mml:mrow><mml:mrow><mml:mtext>HDL</mml:mtext><mml:mo>-</mml:mo><mml:mtext>C</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>mmol</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:mtext>L</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13098_2025_1795_Article_IEq8.gif"/></alternatives></inline-formula> for woman</p></td></tr><tr><td align="left" colspan="2" rowspan="1"><p>Panel 1. Formula for calculating the obesity related indices</p><p>AIP, atherogenic index of plasma; BMI, body mass index (kg/m<sup>2</sup>); CMI, cardiometabolic index; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; LAP, lipid accumulation product; Mets-IR, metabolic score for insulin resistance; TG, triglycerides; TyG, triglyceride-glucose; VAI, visceral adiposity index; WC, waist circumference</p></td></tr></tbody></table></table-wrap></p></sec><sec id="Sec6"><title>Confirmation of&#160;T2DM morbidity</title><p id="Par33">For the diagnosis of diabetes, one blood glucose test is mandatory by the Japanese clinical practice guideline [<xref ref-type="bibr" rid="CR34">34</xref>]. In this study, information on the occurrence of T2DM, including medical and diagnostic procedure combinations and dispensing receipts [<xref ref-type="bibr" rid="CR35">35</xref>], was identified from the database from 2016 to 2021. We reviewed inpatient and outpatient receipts identified based on the International Classification of Diseases, 10th Revision (ICD-10 code) E11-E14 and pharmaceutical classification 396 (antidiabetic agent) for T2DM.</p></sec><sec id="Sec7"><title>Statistical analysis</title><p id="Par34">We employed five age- and sex-specific multiple imputations under the missing-at-random assumption to address missing values in lifestyle variables and clinical measurements to minimise the potential for inference bias, such as blood pressure and cholesterol, using the fcs method. The maximum missing data was 8.1%, observed in variables including smoking among females and hyperlipidemia or hypertension drug therapy in both sexes. Detailed information on the number of missing variables is shown in Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Table&#160;S1. All study results we reported are combined results for imputed datasets.</p><p id="Par35">Descriptive characteristics were presented as means&#8201;&#177;&#8201;SE or median&#8201;&#177;&#8201;IQR for continuous variables and numbers (percentages) for dichotomous variables. A one-way non-parametric test for continuous variables and a chi-square test for categorical variables were used to compare the general characteristics between males and females.</p><p id="Par36">In the preliminary analysis, we observed significant interactions between sex and each index in relation to T2DM risk. Hereafter, we used the sex-specific Cox regression model to estimate the association between obesity indices and T2DM incidence risk in the follow-up period between 2016 and 2021. Person-years were calculated based on the onset date of outpatient or inpatient care (the date on which they were admitted to the hospital or took drugs initially), whichever came first. If there were no recorded death dates, the last health checkup date was recorded as censored. Hazard ratios (HR) and 95% confidence intervals (95% CI) were estimated using the first quartile of indices as the reference. Multivariable regression analyses were conducted with adjustments for variables based on previous publications on cardiovascular risk factors identified in studies involving Fukushima residents [<xref ref-type="bibr" rid="CR36">36</xref>&#8211;<xref ref-type="bibr" rid="CR39">39</xref>]. Collinearity among the indices was checked by using the variance inflation factor (VIF) method before running the regression analyses. Only minor collinearity was found for BMI (VIF&#8201;=&#8201;4.66) and WC (VIF&#8201;=&#8201;4.69) in all covariates in men. Model 1 was adjusted for age, smoking status, alcohol consumption frequency, FPG, SBP, DBP, and use of hypertension or hyperlipidemia drug therapy. Model 2 further included BMI and WC measurements. Model 3 further included the HDL-C (logarithm) and LDL-C (logarithm). In each model, covariates already included in the index formula were excluded from the adjustment [<xref ref-type="bibr" rid="CR40">40</xref>]. BMI, WC, SBP, and DBP were normally distributed. Obesity indices were categorized into quartiles (Q1&#8211;Q4), and a linear trend was evaluated using the median value of lipid indices in the quartile categories as continuous variables. Given the complex role overweight/obesity plays in T2DM development, we assessed the potential interactions between indices and BMI and provided a stratified analysis using a BMI cut-off of 25&#160;kg/m<sup>2</sup>. To further explore age effects, we conducted a stratified analysis for participants aged&#8201;&lt;&#8201;50 years and those aged&#8201;&#8805;&#8201;50 years for T2DM risk.</p><p id="Par37">To examine the dose&#8211;response associations between obesity indices and T2DM risk, we presented restricted cubic spline (RCS) curves with knots at the 5th, 35th, 65th, and 95th percentiles, using the second knot as the reference, for AIP, TyG, and log-transformed CMI, LAP, Mets-IR, and VAI.</p><p id="Par38">Logistic regression models were used to examine the diagnostic utility of the obesity indices based on the area under the receiver operating characteristic curve (AUC). Logarithmic transformation was performed for LAP, CMI, Mets-IR, and VAI. The cutoff values for the obesity indices were estimated based on the Youden index and antilogarithmic transformation was subsequently performed for CMI, LAP, Mets-IR, and VAI. Using the model for AIP as the reference, integrated discrimination improvement (IDI) and net reclassification improvement (NRI) were used to estimate the predictive performance for models of obesity indices.</p><p id="Par39">To address the association of obesity indices with T2DM cases diagnosed later in the follow-up period, we conducted a sensitivity analysis excluding participants diagnosed with T2DM within the first 2 years of follow-up or those taking hypertension or hyperlipidemia therapy drugs. Additionally, regression analyses were performed using the complete case analysis (no imputations) to confirm the study findings. All analyses were conducted separately for males and females to account for lifestyle disparities using SAS version 9.4, for Windows (SAS Institute, Cary, NC). All reported <italic toggle="yes">P</italic> values were two-sided, and <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05 was considered statistically significant.</p></sec></sec><sec id="Sec8"><title>Results</title><p id="Par40">Table <xref rid="Tab1" ref-type="table">1</xref> shows the characteristics of the participants during specific health checkups in 2015. The mean age was 55.2 and 57.8 years for males and females, respectively. Current smoking rates were 40.3% and 10.9%, and daily alcohol consumption were 45.9% and 11.9% in males and females, respectively. Females had higher LDL-C and HDL-C levels and hyperlipidemia drug therapy but lower hypertension drug therapy use compared to males. Other clinical measurements and obesity indices were higher in males than in females.<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Characteristics of participants at baseline</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="2" rowspan="1">Men</th><th align="left" colspan="2" rowspan="1">Women</th><th align="left" rowspan="2" colspan="1"><italic toggle="yes">P</italic> value</th></tr><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="2" rowspan="1">(n&#8201;=&#8201;93,911)</th><th align="left" colspan="2" rowspan="1">(n&#8201;=&#8201;102,078)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Age (years), Mean (SE)</td><td align="left" colspan="2" rowspan="1">55.2 (0.04)</td><td align="left" colspan="2" rowspan="1">57.8 (0.03)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">Current smoking (yes), % (SE)</td><td align="left" colspan="2" rowspan="1">40.3 (0.16)</td><td align="left" colspan="2" rowspan="1">10.9 (0.10)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">Alcohol drinking, % (SE)</td><td align="left" colspan="2" rowspan="1"/><td align="left" colspan="2" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">Every day</td><td align="left" colspan="2" rowspan="1">45.9 (0.17)</td><td align="left" colspan="2" rowspan="1">11.9 (0.10)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Occasionally</td><td align="left" colspan="2" rowspan="1">27.3 (0.15)</td><td align="left" colspan="2" rowspan="1">27.7 (0.14)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Almost no</td><td align="left" colspan="2" rowspan="1">26.8 (0.15)</td><td align="left" colspan="2" rowspan="1">60.4 (0.16)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Hypertension drug therapy (yes), % (SE)</td><td align="left" colspan="2" rowspan="1">23.5 (0.14)</td><td align="left" colspan="2" rowspan="1">22.0 (0.14)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">Hyperlipidemia drug therapy (yes), % (SE)</td><td align="left" colspan="2" rowspan="1">6.8 (0.08)</td><td align="left" colspan="2" rowspan="1">15.9 (0.12)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">BMI (kg/m<sup>2</sup>), Mean (SE)</td><td align="left" colspan="1" rowspan="1">23.8</td><td align="left" colspan="1" rowspan="1">(0.01)</td><td align="left" colspan="1" rowspan="1">22.6</td><td align="left" colspan="1" rowspan="1">(0.01)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">Waist circumference (cm), Mean (SE)</td><td char="." align="char" colspan="1" rowspan="1">84.5</td><td align="left" colspan="1" rowspan="1">(0.03)</td><td char="." align="char" colspan="1" rowspan="1">80.2</td><td align="left" colspan="1" rowspan="1">(0.03)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">SBP (mmHg), Mean (SE)</td><td char="." align="char" colspan="1" rowspan="1">126.9</td><td align="left" colspan="1" rowspan="1">(0.05)</td><td char="." align="char" colspan="1" rowspan="1">123.0</td><td align="left" colspan="1" rowspan="1">(0.05)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">DBP (mmHg), Mean (SE)</td><td char="." align="char" colspan="1" rowspan="1">78.3</td><td align="left" colspan="1" rowspan="1">(0.04)</td><td char="." align="char" colspan="1" rowspan="1">73.8</td><td align="left" colspan="1" rowspan="1">(0.03)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">FPG (mg/dL), Mean (SE)</td><td char="." align="char" colspan="1" rowspan="1">96.6</td><td align="left" colspan="1" rowspan="1">(0.03)</td><td char="." align="char" colspan="1" rowspan="1">93.1</td><td align="left" colspan="1" rowspan="1">(0.03)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">LDL-C (mg/dL), Median (IQR)</td><td char="." align="char" colspan="1" rowspan="1">122.2</td><td align="left" colspan="1" rowspan="1">(102.2, 143.0)</td><td char="." align="char" colspan="1" rowspan="1">123.3</td><td align="left" colspan="1" rowspan="1">(103.4, 144.3)</td><td char="." align="char" colspan="1" rowspan="1">0.008</td></tr><tr><td align="left" colspan="1" rowspan="1">HDL-C (mg/dL), Median (IQR)</td><td char="." align="char" colspan="1" rowspan="1">54.5</td><td align="left" colspan="1" rowspan="1">(46.0, 64.8)</td><td char="." align="char" colspan="1" rowspan="1">65.1</td><td align="left" colspan="1" rowspan="1">(55.6, 76.0)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">Triglyceride (mg/dL), Median (IQR)</td><td char="." align="char" colspan="1" rowspan="1">102.9</td><td align="left" colspan="1" rowspan="1">(72.6, 151.8)</td><td char="." align="char" colspan="1" rowspan="1">79.8</td><td align="left" colspan="1" rowspan="1">(58.5, 110.6)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">AIP, Mean (SE)</td><td char="." align="char" colspan="1" rowspan="1">0.7</td><td align="left" colspan="1" rowspan="1">(0.002)</td><td char="." align="char" colspan="1" rowspan="1">0.2</td><td align="left" colspan="1" rowspan="1">(0.002)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">CMI, Median (IQR)</td><td char="." align="char" colspan="1" rowspan="1">0.9</td><td align="left" colspan="1" rowspan="1">(0.6, 1.6)</td><td char="." align="char" colspan="1" rowspan="1">0.6</td><td align="left" colspan="1" rowspan="1">(0.4, 1.0)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">LAP, Median (IQR)</td><td char="." align="char" colspan="1" rowspan="1">109.2</td><td align="left" colspan="1" rowspan="1">(60.0, 188.2)</td><td char="." align="char" colspan="1" rowspan="1">94.8</td><td align="left" colspan="1" rowspan="1">(53.8, 158.8)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">Mets-IR, Median (IQR)</td><td char="." align="char" colspan="1" rowspan="1">33.6</td><td align="left" colspan="1" rowspan="1">(29.7, 38.1)</td><td char="." align="char" colspan="1" rowspan="1">29.6</td><td align="left" colspan="1" rowspan="1">(26.0, 34.1)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">TyG, Mean (SE)</td><td char="." align="char" colspan="1" rowspan="1">8.5</td><td align="left" colspan="1" rowspan="1">(0.002)</td><td char="." align="char" colspan="1" rowspan="1">8.2</td><td align="left" colspan="1" rowspan="1">(0.002)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">VAI, Median (IQR)</td><td char="." align="char" colspan="1" rowspan="1">2.4</td><td align="left" colspan="1" rowspan="1">(1.5, 4.0)</td><td char="." align="char" colspan="1" rowspan="1">2.3</td><td align="left" colspan="1" rowspan="1">(1.5, 3.6)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.0001</td></tr></tbody></table><table-wrap-foot><p>AIP, atherogenic index of plasma; BMI, body mass index (kg/m<sup>2</sup>); CMI, cardiometabolic index; DBP, diastolic blood pressure (mmHg); FPG, fasting plasma glucose (mg/dL); HDL-C, high-density lipoprotein cholesterol (mg/dL); IQR; interquartile; LAP, lipid accumulation product; LDL-C, low-density lipoprotein cholesterol (mg/dL); Mets-IR, metabolic score for insulin resistance; SBP, systolic blood pressure (mmHg); SE, standard error; TyG, triglyceride-glucose index; VAI, visceral adiposity index</p></table-wrap-foot></table-wrap></p><p id="Par41">Over a mean follow-up duration of 4.61 years, the number (person-years) of new T2DM cases was 3,057 (432,622.3) in males and 2,078 (471,013.0) in females. Thus, the cumulative T2DM incidence rate was 706.6 and 441.2 per 100,000 person-years in males and females, respectively.</p><p id="Par42">Higher obesity index scores were significantly associated with T2DM incidence risk during the follow-up period in multiple adjusted models, with a significant increase in linear trends (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). The associations were more prominent in females than in males and relatively stronger in Mets-IR, TyG, and VAI than in AIP, CMI, and LAP in both males and females.<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Associations between obesity indices and type 2 diabetes mellitus incidence risk</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Model 1</th><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Model 2</th><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Model 3</th><th align="left" colspan="1" rowspan="1"/></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Index</td><td align="left" colspan="1" rowspan="1">Quartile</td><td align="left" colspan="1" rowspan="1">HR</td><td align="left" colspan="1" rowspan="1">95%CI</td><td align="left" colspan="1" rowspan="1">HR</td><td align="left" colspan="1" rowspan="1">95%CI</td><td align="left" colspan="1" rowspan="1">HR</td><td align="left" colspan="1" rowspan="1">95%CI</td></tr><tr><td align="left" colspan="1" rowspan="1">Men</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">AIP</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">1.08</td><td align="left" colspan="1" rowspan="1">(0.84, 1.38)</td><td align="left" colspan="1" rowspan="1">0.91</td><td align="left" colspan="1" rowspan="1">(0.71, 1.17)</td><td align="left" colspan="1" rowspan="1">0.91</td><td align="left" colspan="1" rowspan="1">(0.71, 1.17)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">1.41</td><td align="left" colspan="1" rowspan="1">(1.12, 1.76)</td><td align="left" colspan="1" rowspan="1">1.04</td><td align="left" colspan="1" rowspan="1">(0.83, 1.31)</td><td align="left" colspan="1" rowspan="1">1.03</td><td align="left" colspan="1" rowspan="1">(0.82, 1.30)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">2.26</td><td align="left" colspan="1" rowspan="1">(1.83, 2.80)</td><td align="left" colspan="1" rowspan="1">1.45</td><td align="left" colspan="1" rowspan="1">(1.17, 1.81)</td><td align="left" colspan="1" rowspan="1">1.44</td><td align="left" colspan="1" rowspan="1">(1.16, 1.80)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for trend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">CMI</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">1.01</td><td align="left" colspan="1" rowspan="1">(0.79, 1.31)</td><td align="left" colspan="1" rowspan="1">0.88</td><td align="left" colspan="1" rowspan="1">(0.68, 1.13)</td><td align="left" colspan="1" rowspan="1">0.87</td><td align="left" colspan="1" rowspan="1">(0.68, 1.13)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">1.56</td><td align="left" colspan="1" rowspan="1">(1.24, 1.96)</td><td align="left" colspan="1" rowspan="1">1.15</td><td align="left" colspan="1" rowspan="1">(0.91, 1.45)</td><td align="left" colspan="1" rowspan="1">1.14</td><td align="left" colspan="1" rowspan="1">(0.90, 1.44)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">2.42</td><td align="left" colspan="1" rowspan="1">(1.95, 3.00)</td><td align="left" colspan="1" rowspan="1">1.5</td><td align="left" colspan="1" rowspan="1">(1.20, 1.87)</td><td align="left" colspan="1" rowspan="1">1.48</td><td align="left" colspan="1" rowspan="1">(1.18, 1.86)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for trend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">LAP</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">1.28</td><td align="left" colspan="1" rowspan="1">(1.02, 1.61)</td><td align="left" colspan="1" rowspan="1">1.01</td><td align="left" colspan="1" rowspan="1">(0.80, 1.28)</td><td align="left" colspan="1" rowspan="1">0.94</td><td align="left" colspan="1" rowspan="1">(0.75, 1.19)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">1.75</td><td align="left" colspan="1" rowspan="1">(1.42, 2.17)</td><td align="left" colspan="1" rowspan="1">1.16</td><td align="left" colspan="1" rowspan="1">(0.94, 1.45)</td><td align="left" colspan="1" rowspan="1">1.02</td><td align="left" colspan="1" rowspan="1">(0.81, 1.28)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">3.19</td><td align="left" colspan="1" rowspan="1">(2.62, 3.89)</td><td align="left" colspan="1" rowspan="1">1.65</td><td align="left" colspan="1" rowspan="1">(1.33, 2.05)</td><td align="left" colspan="1" rowspan="1">1.33</td><td align="left" colspan="1" rowspan="1">(1.05, 1.69)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for trend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Mets-IR</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">1.41</td><td align="left" colspan="1" rowspan="1">(1.04, 1.92)</td><td align="left" colspan="1" rowspan="1">1.08</td><td align="left" colspan="1" rowspan="1">(0.79, 1.47)</td><td align="left" colspan="1" rowspan="1">1.05</td><td align="left" colspan="1" rowspan="1">(0.77, 1.43)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">2.14</td><td align="left" colspan="1" rowspan="1">(1.61, 2.85)</td><td align="left" colspan="1" rowspan="1">1.26</td><td align="left" colspan="1" rowspan="1">(0.94, 1.69)</td><td align="left" colspan="1" rowspan="1">1.21</td><td align="left" colspan="1" rowspan="1">(0.90, 1.62)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">5.58</td><td align="left" colspan="1" rowspan="1">(4.25, 7.32)</td><td align="left" colspan="1" rowspan="1">2.18</td><td align="left" colspan="1" rowspan="1">(1.61, 2.94)</td><td align="left" colspan="1" rowspan="1">2.08</td><td align="left" colspan="1" rowspan="1">(1.53, 2.81)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for trend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">TyG</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">1.26</td><td align="left" colspan="1" rowspan="1">(0.97, 1.65)</td><td align="left" colspan="1" rowspan="1">1.09</td><td align="left" colspan="1" rowspan="1">(0.84, 1.43)</td><td align="left" colspan="1" rowspan="1">1.05</td><td align="left" colspan="1" rowspan="1">(0.81, 1.38)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">1.97</td><td align="left" colspan="1" rowspan="1">(1.55, 2.51)</td><td align="left" colspan="1" rowspan="1">1.45</td><td align="left" colspan="1" rowspan="1">(1.13, 1.85)</td><td align="left" colspan="1" rowspan="1">1.35</td><td align="left" colspan="1" rowspan="1">(1.05, 1.73)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">3.95</td><td align="left" colspan="1" rowspan="1">(3.15, 4.95)</td><td align="left" colspan="1" rowspan="1">2.49</td><td align="left" colspan="1" rowspan="1">(1.98, 3.14)</td><td align="left" colspan="1" rowspan="1">2.21</td><td align="left" colspan="1" rowspan="1">(1.73, 2.83)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for trend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">VAI</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">1.34</td><td align="left" colspan="1" rowspan="1">(1.09, 1.64)</td><td align="left" colspan="1" rowspan="1">1.34</td><td align="left" colspan="1" rowspan="1">(1.09, 1.64)</td><td align="left" colspan="1" rowspan="1">1.31</td><td align="left" colspan="1" rowspan="1">(1.07, 1.61)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">1.8</td><td align="left" colspan="1" rowspan="1">(1.49, 2.17)</td><td align="left" colspan="1" rowspan="1">1.8</td><td align="left" colspan="1" rowspan="1">(1.49, 2.17)</td><td align="left" colspan="1" rowspan="1">1.74</td><td align="left" colspan="1" rowspan="1">(1.44, 2.11)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">2.53</td><td align="left" colspan="1" rowspan="1">(2.12, 3.02)</td><td align="left" colspan="1" rowspan="1">2.53</td><td align="left" colspan="1" rowspan="1">(2.12, 3.02)</td><td align="left" colspan="1" rowspan="1">2.45</td><td align="left" colspan="1" rowspan="1">(2.05, 2.94)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for trend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Women</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">AIP</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">1.49</td><td align="left" colspan="1" rowspan="1">(1.18, 1.87)</td><td align="left" colspan="1" rowspan="1">1.29</td><td align="left" colspan="1" rowspan="1">(1.02, 1.62)</td><td align="left" colspan="1" rowspan="1">1.28</td><td align="left" colspan="1" rowspan="1">(1.02, 1.61)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">2.06</td><td align="left" colspan="1" rowspan="1">(1.65, 2.56)</td><td align="left" colspan="1" rowspan="1">1.54</td><td align="left" colspan="1" rowspan="1">(1.23, 1.93)</td><td align="left" colspan="1" rowspan="1">1.53</td><td align="left" colspan="1" rowspan="1">(1.22, 1.92)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">3.13</td><td align="left" colspan="1" rowspan="1">(2.51, 3.90)</td><td align="left" colspan="1" rowspan="1">2.14</td><td align="left" colspan="1" rowspan="1">(1.70, 2.68)</td><td align="left" colspan="1" rowspan="1">2.12</td><td align="left" colspan="1" rowspan="1">(1.68, 2.67)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for trend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">CMI</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">1.71</td><td align="left" colspan="1" rowspan="1">(1.33, 2.20)</td><td align="left" colspan="1" rowspan="1">1.43</td><td align="left" colspan="1" rowspan="1">(1.11, 1.84)</td><td align="left" colspan="1" rowspan="1">1.42</td><td align="left" colspan="1" rowspan="1">(1.10, 1.84)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">2.38</td><td align="left" colspan="1" rowspan="1">(1.87, 3.04)</td><td align="left" colspan="1" rowspan="1">1.72</td><td align="left" colspan="1" rowspan="1">(1.34, 2.20)</td><td align="left" colspan="1" rowspan="1">1.70</td><td align="left" colspan="1" rowspan="1">(1.32, 2.19)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">3.93</td><td align="left" colspan="1" rowspan="1">(3.10, 4.99)</td><td align="left" colspan="1" rowspan="1">2.42</td><td align="left" colspan="1" rowspan="1">(1.88, 3.12)</td><td align="left" colspan="1" rowspan="1">2.39</td><td align="left" colspan="1" rowspan="1">(1.84, 3.10)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for trend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">LAP</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">1.77</td><td align="left" colspan="1" rowspan="1">(1.30, 2.41)</td><td align="left" colspan="1" rowspan="1">1.43</td><td align="left" colspan="1" rowspan="1">(1.05, 1.95)</td><td align="left" colspan="1" rowspan="1">1.34</td><td align="left" colspan="1" rowspan="1">(0.98, 1.83)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">2.43</td><td align="left" colspan="1" rowspan="1">(1.82, 3.25)</td><td align="left" colspan="1" rowspan="1">1.65</td><td align="left" colspan="1" rowspan="1">(1.22, 2.22)</td><td align="left" colspan="1" rowspan="1">1.42</td><td align="left" colspan="1" rowspan="1">(1.04, 1.94)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">4.22</td><td align="left" colspan="1" rowspan="1">(3.19, 5.58)</td><td align="left" colspan="1" rowspan="1">2.23</td><td align="left" colspan="1" rowspan="1">(1.63, 3.04)</td><td align="left" colspan="1" rowspan="1">1.70</td><td align="left" colspan="1" rowspan="1">(1.22, 2.38)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for trend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.0033</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Mets-IR</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">1.75</td><td align="left" colspan="1" rowspan="1">(1.36, 2.25)</td><td align="left" colspan="1" rowspan="1">1.44</td><td align="left" colspan="1" rowspan="1">(1.11, 1.87)</td><td align="left" colspan="1" rowspan="1">1.39</td><td align="left" colspan="1" rowspan="1">(1.07, 1.81)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">2.51</td><td align="left" colspan="1" rowspan="1">(1.97, 3.21)</td><td align="left" colspan="1" rowspan="1">1.78</td><td align="left" colspan="1" rowspan="1">(1.36, 2.32)</td><td align="left" colspan="1" rowspan="1">1.69</td><td align="left" colspan="1" rowspan="1">(1.29, 2.21)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">8.01</td><td align="left" colspan="1" rowspan="1">(6.42, 10.00)</td><td align="left" colspan="1" rowspan="1">4.49</td><td align="left" colspan="1" rowspan="1">(3.36, 6.02)</td><td align="left" colspan="1" rowspan="1">4.22</td><td align="left" colspan="1" rowspan="1">(3.15, 5.66)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for trend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">TyG</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">1.70</td><td align="left" colspan="1" rowspan="1">(1.31, 2.19)</td><td align="left" colspan="1" rowspan="1">1.41</td><td align="left" colspan="1" rowspan="1">(1.09, 1.83)</td><td align="left" colspan="1" rowspan="1">1.35</td><td align="left" colspan="1" rowspan="1">(1.04, 1.74)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">3.12</td><td align="left" colspan="1" rowspan="1">(2.45, 3.98)</td><td align="left" colspan="1" rowspan="1">2.20</td><td align="left" colspan="1" rowspan="1">(1.72, 2.81)</td><td align="left" colspan="1" rowspan="1">1.99</td><td align="left" colspan="1" rowspan="1">(1.54, 2.57)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">6.18</td><td align="left" colspan="1" rowspan="1">(4.89, 7.80)</td><td align="left" colspan="1" rowspan="1">3.77</td><td align="left" colspan="1" rowspan="1">(2.97, 4.79)</td><td align="left" colspan="1" rowspan="1">3.18</td><td align="left" colspan="1" rowspan="1">(2.44, 4.14)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for trend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">VAI</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">1.40</td><td align="left" colspan="1" rowspan="1">(1.05, 1.87)</td><td align="left" colspan="1" rowspan="1">1.40</td><td align="left" colspan="1" rowspan="1">(1.05, 1.87)</td><td align="left" colspan="1" rowspan="1">1.38</td><td align="left" colspan="1" rowspan="1">(1.03, 1.84)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">2.10</td><td align="left" colspan="1" rowspan="1">(1.60, 2.74)</td><td align="left" colspan="1" rowspan="1">2.10</td><td align="left" colspan="1" rowspan="1">(1.60, 2.74)</td><td align="left" colspan="1" rowspan="1">2.04</td><td align="left" colspan="1" rowspan="1">(1.55, 2.67)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">3.21</td><td align="left" colspan="1" rowspan="1">(2.48, 4.16)</td><td align="left" colspan="1" rowspan="1">3.21</td><td align="left" colspan="1" rowspan="1">(2.48, 4.16)</td><td align="left" colspan="1" rowspan="1">3.09</td><td align="left" colspan="1" rowspan="1">(2.37, 4.03)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for trend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/></tr></tbody></table><table-wrap-foot><p>AIP, atherogenic index of plasma; CI, confidence interval; CMI, cardiometabolic index; HR, hazard ratio; LAP, lipid accumulation product; Mets-IR, metabolic score for insulin resistance; TyG, triglyceride-glucose index; VAI, visceral adiposity index</p><p>Model 1: adjusted for age (continue), smoking (no/yes), alcohol drinking (almost no/occasional/every day), hypertension drug therapy (no/yes), hyperlipidemia drug therapy (no/yes), systolic blood pressure (mmHg), diastolic blood pressure (mmHg), and fast plasma glucose (mg/dL); Model 2 further adjusted for body mass index (kg/m<sup>2</sup>), and waist circumference (cm); Model 3 further adjusted for high-density lipoprotein cholesterol (mg/dL) and low-density lipoprotein cholesterol (mg/dL). In each model, the adjustment excluded those that had already been included in the index formula</p></table-wrap-foot></table-wrap></p><p id="Par43">After excluding participants diagnosed with T2DM in the first 2 years of follow-up or those using hypertension or hyperlipidemia drug therapy, significant positive associations between the indices and T2DM risk remained in both males and females. The magnitudes of the associations were similar between the two sensitivity analyses for each index (Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Table&#160;S1). Similar significant associations between the indices and T2DM risk were shown by repeated the complete case analysis (without imputations) (Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Table&#160;S2).</p><p id="Par44">In addition, in further stratified analysis, few participants with BMI&#8201;&#8805;&#8201;25 kg/m<sup>2</sup> in the Q1 and Q2 groups of Mets-IR, only HR and 95% CI of Q4 vs. Q3 were shown. In participants who were overweight/obese significant positive associations between the indices and T2DM incidence risk, except for LAP, were observed (Table&#160;<xref rid="Tab3" ref-type="table">3</xref>). The increased risk of T2DM incidence in higher quartiles versus the lowest quartile for each index was more pronounced in participants aged&#8201;&lt;&#8201;50 years than in those aged&#8201;&#8805;&#8201;50 years in both sexes (Table&#160;<xref rid="Tab4" ref-type="table">4</xref>).<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Associations between obesity indices and type 2 diabetes mellitus incidence risk by overweight/obese status</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3" colspan="1">Index</th><th align="left" rowspan="3" colspan="1">Quartile</th><th align="left" colspan="4" rowspan="1">Men</th><th align="left" colspan="4" rowspan="1">Women</th></tr><tr><th align="left" colspan="2" rowspan="1">BMI&#8201;&lt;&#8201;25&#160;kg/m<sup>2</sup></th><th align="left" colspan="2" rowspan="1">BMI&#8201;&#8805;&#8201;25&#160;kg/m<sup>2</sup></th><th align="left" colspan="2" rowspan="1">BMI&#8201;&lt;&#8201;25&#160;kg/m<sup>2</sup></th><th align="left" colspan="2" rowspan="1">BMI&#8201;&#8805;&#8201;25&#160;kg/m<sup>2</sup></th></tr><tr><th align="left" colspan="1" rowspan="1">HR</th><th align="left" colspan="1" rowspan="1">95% CI</th><th align="left" colspan="1" rowspan="1">HR</th><th align="left" colspan="1" rowspan="1">95% CI</th><th align="left" colspan="1" rowspan="1">HR</th><th align="left" colspan="1" rowspan="1">95% CI</th><th align="left" colspan="1" rowspan="1">HR</th><th align="left" colspan="1" rowspan="1">95% CI</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">AIP</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">0.92</td><td align="left" colspan="1" rowspan="1">(0.76, 1.12)</td><td align="left" colspan="1" rowspan="1">1.14</td><td align="left" colspan="1" rowspan="1">(0.84, 1.54)</td><td align="left" colspan="1" rowspan="1">1.34</td><td align="left" colspan="1" rowspan="1">(1.11, 1.62)</td><td align="left" colspan="1" rowspan="1">1.36</td><td align="left" colspan="1" rowspan="1">(1.03, 1.79)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">1.01</td><td align="left" colspan="1" rowspan="1">(0.84, 1.21)</td><td align="left" colspan="1" rowspan="1">1.23</td><td align="left" colspan="1" rowspan="1">(0.92, 1.64)</td><td align="left" colspan="1" rowspan="1">1.52</td><td align="left" colspan="1" rowspan="1">(1.26, 1.85)</td><td align="left" colspan="1" rowspan="1">1.74</td><td align="left" colspan="1" rowspan="1">(1.34, 2.26)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">1.34</td><td align="left" colspan="1" rowspan="1">(1.12, 1.61)</td><td align="left" colspan="1" rowspan="1">1.50</td><td align="left" colspan="1" rowspan="1">(1.13, 1.98)</td><td align="left" colspan="1" rowspan="1">2.21</td><td align="left" colspan="1" rowspan="1">(1.82, 2.69)</td><td align="left" colspan="1" rowspan="1">2.25</td><td align="left" colspan="1" rowspan="1">(1.74, 2.91)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for rend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">CMI</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">0.89</td><td align="left" colspan="1" rowspan="1">(0.73, 1.07)</td><td align="left" colspan="1" rowspan="1">1.01</td><td align="left" colspan="1" rowspan="1">(0.71, 1.45)</td><td align="left" colspan="1" rowspan="1">1.29</td><td align="left" colspan="1" rowspan="1">(1.06, 1.56)</td><td align="left" colspan="1" rowspan="1">1.32</td><td align="left" colspan="1" rowspan="1">(0.89, 1.96)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">1.05</td><td align="left" colspan="1" rowspan="1">(0.87, 1.26)</td><td align="left" colspan="1" rowspan="1">1.17</td><td align="left" colspan="1" rowspan="1">(0.83, 1.63)</td><td align="left" colspan="1" rowspan="1">1.48</td><td align="left" colspan="1" rowspan="1">(1.21, 1.80)</td><td align="left" colspan="1" rowspan="1">1.87</td><td align="left" colspan="1" rowspan="1">(1.29, 2.71)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">1.35</td><td align="left" colspan="1" rowspan="1">(1.13, 1.61)</td><td align="left" colspan="1" rowspan="1">1.41</td><td align="left" colspan="1" rowspan="1">(1.01, 1.96)</td><td align="left" colspan="1" rowspan="1">2.23</td><td align="left" colspan="1" rowspan="1">(1.82, 2.74)</td><td align="left" colspan="1" rowspan="1">2.50</td><td align="left" colspan="1" rowspan="1">(1.73, 3.61)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for rend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">LAP</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">0.98</td><td align="left" colspan="1" rowspan="1">(0.82, 1.17)</td><td align="left" colspan="1" rowspan="1">0.77</td><td align="left" colspan="1" rowspan="1">(0.44, 1.35)</td><td align="left" colspan="1" rowspan="1">1.23</td><td align="left" colspan="1" rowspan="1">(0.98, 1.53)</td><td align="left" colspan="1" rowspan="1">0.95</td><td align="left" colspan="1" rowspan="1">(0.34, 2.61)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">1.06</td><td align="left" colspan="1" rowspan="1">(0.87, 1.28)</td><td align="left" colspan="1" rowspan="1">0.89</td><td align="left" colspan="1" rowspan="1">(0.52, 1.52)</td><td align="left" colspan="1" rowspan="1">1.50</td><td align="left" colspan="1" rowspan="1">(1.19, 1.90)</td><td align="left" colspan="1" rowspan="1">0.95</td><td align="left" colspan="1" rowspan="1">(0.35, 2.58)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">1.44</td><td align="left" colspan="1" rowspan="1">(1.17, 1.76)</td><td align="left" colspan="1" rowspan="1">0.98</td><td align="left" colspan="1" rowspan="1">(0.57, 1.68)</td><td align="left" colspan="1" rowspan="1">1.60</td><td align="left" colspan="1" rowspan="1">(1.23, 2.09)</td><td align="left" colspan="1" rowspan="1">1.24</td><td align="left" colspan="1" rowspan="1">(0.46, 3.35)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for rend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.022</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.0018</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.0009</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Mets-IR</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">1.37</td><td align="left" colspan="1" rowspan="1">(1.10, 1.70)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">1.55</td><td align="left" colspan="1" rowspan="1">(1.29, 1.87)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">1.81</td><td align="left" colspan="1" rowspan="1">(1.44, 2.28)</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">2.65</td><td align="left" colspan="1" rowspan="1">(2.15, 3.26)</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">3.18</td><td align="left" colspan="1" rowspan="1">(2.47, 4.09)</td><td align="left" colspan="1" rowspan="1">1.72</td><td align="left" colspan="1" rowspan="1">(1.43, 2.06)</td><td align="left" colspan="1" rowspan="1">4.53</td><td align="left" colspan="1" rowspan="1">(3.41, 6.01)</td><td align="left" colspan="1" rowspan="1">2.16</td><td align="left" colspan="1" rowspan="1">(1.81, 2.59)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for rend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">TyG</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">1.05</td><td align="left" colspan="1" rowspan="1">(0.85, 1.30)</td><td align="left" colspan="1" rowspan="1">1.17</td><td align="left" colspan="1" rowspan="1">(0.87, 1.58)</td><td align="left" colspan="1" rowspan="1">1.63</td><td align="left" colspan="1" rowspan="1">(1.31, 2.01)</td><td align="left" colspan="1" rowspan="1">1.21</td><td align="left" colspan="1" rowspan="1">(0.90, 1.64)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">1.42</td><td align="left" colspan="1" rowspan="1">(1.16, 1.73)</td><td align="left" colspan="1" rowspan="1">1.52</td><td align="left" colspan="1" rowspan="1">(1.15, 2.00)</td><td align="left" colspan="1" rowspan="1">2.39</td><td align="left" colspan="1" rowspan="1">(1.92, 2.97)</td><td align="left" colspan="1" rowspan="1">1.85</td><td align="left" colspan="1" rowspan="1">(1.40, 2.45)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">2.36</td><td align="left" colspan="1" rowspan="1">(1.93, 2.87)</td><td align="left" colspan="1" rowspan="1">2.17</td><td align="left" colspan="1" rowspan="1">(1.65, 2.84)</td><td align="left" colspan="1" rowspan="1">4.09</td><td align="left" colspan="1" rowspan="1">(3.24, 5.16)</td><td align="left" colspan="1" rowspan="1">2.83</td><td align="left" colspan="1" rowspan="1">(2.13, 3.76)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for rend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">VAI</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">1.05</td><td align="left" colspan="1" rowspan="1">(0.89, 1.24)</td><td align="left" colspan="1" rowspan="1">1.37</td><td align="left" colspan="1" rowspan="1">(1.10, 1.71)</td><td align="left" colspan="1" rowspan="1">1.23</td><td align="left" colspan="1" rowspan="1">(0.99, 1.53)</td><td align="left" colspan="1" rowspan="1">1.67</td><td align="left" colspan="1" rowspan="1">(1.10, 2.56)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">1.25</td><td align="left" colspan="1" rowspan="1">(1.06, 1.47)</td><td align="left" colspan="1" rowspan="1">1.42</td><td align="left" colspan="1" rowspan="1">(1.15, 1.76)</td><td align="left" colspan="1" rowspan="1">1.53</td><td align="left" colspan="1" rowspan="1">(1.24, 1.89)</td><td align="left" colspan="1" rowspan="1">2.38</td><td align="left" colspan="1" rowspan="1">(1.59, 3.56)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">1.61</td><td align="left" colspan="1" rowspan="1">(1.38, 1.88)</td><td align="left" colspan="1" rowspan="1">1.71</td><td align="left" colspan="1" rowspan="1">(1.39, 2.09)</td><td align="left" colspan="1" rowspan="1">2.25</td><td align="left" colspan="1" rowspan="1">(1.83, 2.76)</td><td align="left" colspan="1" rowspan="1">3.06</td><td align="left" colspan="1" rowspan="1">(2.06, 4.55)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for rend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/></tr></tbody></table><table-wrap-foot><p>AIP, atherogenic index of plasma; CI, confidence interval; CMI, cardiometabolic index; HR, hazard ratio; LAP, lipid accumulation product; Mets-IR, metabolic score for insulin resistance; TyG, triglyceride-glucose index; VAI, visceral adiposity index</p><p>Models were adjusted for age (continue), smoking (no/yes), alcohol drinking (almost no/occasional/every day), hypertension drug therapy (no/yes), hyperlipidemia drug therapy (no/yes), systolic blood pressure (mmHg), diastolic blood pressure (mmHg), fast plasma glucose (mg/dL), body mass index (kg/m<sup>2</sup>), waist circumference (cm), high-density lipoprotein cholesterol (mg/dL), and low-density lipoprotein cholesterol (mg/dL). In each model, the adjustment excluded those that had already been included in the index formula</p></table-wrap-foot></table-wrap><table-wrap id="Tab4" position="float" orientation="portrait"><label>Table 4</label><caption><p>Associations between obesity indices and type 2 diabetes mellitus incidence risk by age groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3" colspan="1">Index</th><th align="left" rowspan="3" colspan="1">Quartile</th><th align="left" colspan="4" rowspan="1">Men</th><th align="left" colspan="4" rowspan="1">Women</th></tr><tr><th align="left" colspan="1" rowspan="1">Age&#8201;&lt;&#8201;50 years</th><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="2" rowspan="1">Age&#8201;&#8805;&#8201;50 years</th><th align="left" colspan="2" rowspan="1">Age&#8201;&lt;&#8201;50 years</th><th align="left" colspan="2" rowspan="1">Age&#8201;&#8805;&#8201;50 years</th></tr><tr><th align="left" colspan="1" rowspan="1">HR</th><th align="left" colspan="1" rowspan="1">95% CI</th><th align="left" colspan="1" rowspan="1">HR</th><th align="left" colspan="1" rowspan="1">95% CI</th><th align="left" colspan="1" rowspan="1">HR</th><th align="left" colspan="1" rowspan="1">95% CI</th><th align="left" colspan="1" rowspan="1">HR</th><th align="left" colspan="1" rowspan="1">95% CI</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">AIP</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">1.50</td><td align="left" colspan="1" rowspan="1">(0.88, 2.56)</td><td align="left" colspan="1" rowspan="1">0.92</td><td align="left" colspan="1" rowspan="1">(0.78, 1.09)</td><td align="left" colspan="1" rowspan="1">1.40</td><td align="left" colspan="1" rowspan="1">(0.88, 2.22)</td><td align="left" colspan="1" rowspan="1">1.34</td><td align="left" colspan="1" rowspan="1">(1.14, 1.57)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">1.65</td><td align="left" colspan="1" rowspan="1">(0.99, 2.73)</td><td align="left" colspan="1" rowspan="1">1.02</td><td align="left" colspan="1" rowspan="1">(0.87, 1.19)</td><td align="left" colspan="1" rowspan="1">1.96</td><td align="left" colspan="1" rowspan="1">(1.24, 3.11)</td><td align="left" colspan="1" rowspan="1">1.59</td><td align="left" colspan="1" rowspan="1">(1.36, 1.92)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">2.35</td><td align="left" colspan="1" rowspan="1">(1.45, 3.83)</td><td align="left" colspan="1" rowspan="1">1.27</td><td align="left" colspan="1" rowspan="1">(1.09, 1.48)</td><td align="left" colspan="1" rowspan="1">3.87</td><td align="left" colspan="1" rowspan="1">(2.48, 6.04)</td><td align="left" colspan="1" rowspan="1">2.08</td><td align="left" colspan="1" rowspan="1">(1.77, 2.43)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for trend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">CMI</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">1.49</td><td align="left" colspan="1" rowspan="1">(0.86, 2.56)</td><td align="left" colspan="1" rowspan="1">0.86</td><td align="left" colspan="1" rowspan="1">(0.73, 1.03)</td><td align="left" colspan="1" rowspan="1">0.89</td><td align="left" colspan="1" rowspan="1">0.53, 1.48)</td><td align="left" colspan="1" rowspan="1">1.32</td><td align="left" colspan="1" rowspan="1">(1.11, 1.58)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">1.81</td><td align="left" colspan="1" rowspan="1">(1.09, 3.01)</td><td align="left" colspan="1" rowspan="1">1.02</td><td align="left" colspan="1" rowspan="1">(0.87, 1.19)</td><td align="left" colspan="1" rowspan="1">1.74</td><td align="left" colspan="1" rowspan="1">(1.09, 2.79)</td><td align="left" colspan="1" rowspan="1">1.61</td><td align="left" colspan="1" rowspan="1">(1.36, 1.92)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">2.57</td><td align="left" colspan="1" rowspan="1">(1.57, 4.21)</td><td align="left" colspan="1" rowspan="1">1.24</td><td align="left" colspan="1" rowspan="1">(1.06, 1.45)</td><td align="left" colspan="1" rowspan="1">4.16</td><td align="left" colspan="1" rowspan="1">(2.63, 6.57)</td><td align="left" colspan="1" rowspan="1">2.15</td><td align="left" colspan="1" rowspan="1">(1.81, 2.57)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for trend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">LAP</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">0.81</td><td align="left" colspan="1" rowspan="1">(0.51, 1.31)</td><td align="left" colspan="1" rowspan="1">0.94</td><td align="left" colspan="1" rowspan="1">(0.80, 1.11)</td><td align="left" colspan="1" rowspan="1">1.00</td><td align="left" colspan="1" rowspan="1">(0.58, 1.72)</td><td align="left" colspan="1" rowspan="1">1.15</td><td align="left" colspan="1" rowspan="1">(0.93, 1.43)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">1.20</td><td align="left" colspan="1" rowspan="1">(0.79, 1.83)</td><td align="left" colspan="1" rowspan="1">1.02</td><td align="left" colspan="1" rowspan="1">(0.87, 1.19)</td><td align="left" colspan="1" rowspan="1">1.21</td><td align="left" colspan="1" rowspan="1">(0.70, 2.09)</td><td align="left" colspan="1" rowspan="1">1.31</td><td align="left" colspan="1" rowspan="1">(1.06, 1.62)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">1.70</td><td align="left" colspan="1" rowspan="1">(1.11, 2.60)</td><td align="left" colspan="1" rowspan="1">1.22</td><td align="left" colspan="1" rowspan="1">(1.02, 1.45)</td><td align="left" colspan="1" rowspan="1">2.67</td><td align="left" colspan="1" rowspan="1">(1.51, 4.72)</td><td align="left" colspan="1" rowspan="1">1.47</td><td align="left" colspan="1" rowspan="1">(1.17, 1.85)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for trend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.0005</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Mets-IR</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">0.90</td><td align="left" colspan="1" rowspan="1">(0.46, 1.74)</td><td align="left" colspan="1" rowspan="1">1.23</td><td align="left" colspan="1" rowspan="1">(0.99, 1.54)</td><td align="left" colspan="1" rowspan="1">1.32</td><td align="left" colspan="1" rowspan="1">(0.74, 2.35)</td><td align="left" colspan="1" rowspan="1">1.41</td><td align="left" colspan="1" rowspan="1">(1.18, 1.70)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">1.27</td><td align="left" colspan="1" rowspan="1">(1.69, 2.31)</td><td align="left" colspan="1" rowspan="1">1.40</td><td align="left" colspan="1" rowspan="1">(1.13, 1.73)</td><td align="left" colspan="1" rowspan="1">2.15</td><td align="left" colspan="1" rowspan="1">(1.22, 3.80)</td><td align="left" colspan="1" rowspan="1">2.24</td><td align="left" colspan="1" rowspan="1">(1.86, 2.70)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">2.75</td><td align="left" colspan="1" rowspan="1">(1.53, 4.96)</td><td align="left" colspan="1" rowspan="1">2.31</td><td align="left" colspan="1" rowspan="1">(1.85, 2.89)</td><td align="left" colspan="1" rowspan="1">7.79</td><td align="left" colspan="1" rowspan="1">(4.49, 13.53)</td><td align="left" colspan="1" rowspan="1">4.21</td><td align="left" colspan="1" rowspan="1">(3.42, 5.18)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for trend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">TyG</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">0.90</td><td align="left" colspan="1" rowspan="1">(0.56, 1.44)</td><td align="left" colspan="1" rowspan="1">1.10</td><td align="left" colspan="1" rowspan="1">(0.92, 1.32)</td><td align="left" colspan="1" rowspan="1">1.37</td><td align="left" colspan="1" rowspan="1">(0.85, 2.19)</td><td align="left" colspan="1" rowspan="1">1.45</td><td align="left" colspan="1" rowspan="1">(1.20, 1.74)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">1.49</td><td align="left" colspan="1" rowspan="1">(0.98, 2.28)</td><td align="left" colspan="1" rowspan="1">1.41</td><td align="left" colspan="1" rowspan="1">(1.18, 1.67)</td><td align="left" colspan="1" rowspan="1">2.20</td><td align="left" colspan="1" rowspan="1">(1.38, 3.48)</td><td align="left" colspan="1" rowspan="1">2.13</td><td align="left" colspan="1" rowspan="1">(1.78, 2.56)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">2.34</td><td align="left" colspan="1" rowspan="1">(1.55, 3.51)</td><td align="left" colspan="1" rowspan="1">2.15</td><td align="left" colspan="1" rowspan="1">(1.81, 2.55)</td><td align="left" colspan="1" rowspan="1">4.83</td><td align="left" colspan="1" rowspan="1">(3.03, 7.70)</td><td align="left" colspan="1" rowspan="1">3.32</td><td align="left" colspan="1" rowspan="1">(2.75, 4.01)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for trend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">VAI</td><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">1.68</td><td align="left" colspan="1" rowspan="1">(1.14, 2.47)</td><td align="left" colspan="1" rowspan="1">1.19</td><td align="left" colspan="1" rowspan="1">(1.04, 1.37)</td><td align="left" colspan="1" rowspan="1">1.31</td><td align="left" colspan="1" rowspan="1">(0.76, 2.26)</td><td align="left" colspan="1" rowspan="1">1.41</td><td align="left" colspan="1" rowspan="1">(1.15, 1.72)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">2.06</td><td align="left" colspan="1" rowspan="1">(1.43, 2.95)</td><td align="left" colspan="1" rowspan="1">1.41</td><td align="left" colspan="1" rowspan="1">(1.23, 1.61)</td><td align="left" colspan="1" rowspan="1">2.07</td><td align="left" colspan="1" rowspan="1">(1.23, 3.47)</td><td align="left" colspan="1" rowspan="1">1.96</td><td align="left" colspan="1" rowspan="1">(1.62, 2.37)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">3.47</td><td align="left" colspan="1" rowspan="1">(2.47, 4.87)</td><td align="left" colspan="1" rowspan="1">1.76</td><td align="left" colspan="1" rowspan="1">(1.56, 1.99)</td><td align="left" colspan="1" rowspan="1">5.60</td><td align="left" colspan="1" rowspan="1">(3.46, 9.05)</td><td align="left" colspan="1" rowspan="1">2.69</td><td align="left" colspan="1" rowspan="1">(2.24, 3.24)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> for trend</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1"/></tr></tbody></table><table-wrap-foot><p>AIP, atherogenic index of plasma; CI, confidence interval; CMI, cardiometabolic index; HR, hazard ratio; LAP, lipid accumulation product; Mets-IR, metabolic score for insulin resistance; TyG, triglyceride-glucose index; VAI, visceral adiposity index</p><p>Models were adjusted for age (continue), smoking (no/yes), alcohol drinking (almost no/occasional/every day), hypertension drug therapy (no/yes), hyperlipidemia drug therapy (no/yes), systolic blood pressure (mmHg), diastolic blood pressure (mmHg), fast plasma glucose (mg/dL), body mass index (kg/m<sup>2</sup>), waist circumference (cm), high-density lipoprotein cholesterol (mg/dL), and low-density lipoprotein cholesterol (mg/dL). The adjustment excluded those already included in the index formula in each model</p></table-wrap-foot></table-wrap></p><p id="Par45">The AUCs of the obesity indices for the identification of new T2DM cases were higher in females than in males. AUCs were 0.821&#8211;0.844 for AIP, CMI, LAP, and VAI nd 0.756&#8211;0.780 for Mets-IR and TyG (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref> and Table&#160;<xref rid="Tab5" ref-type="table">5</xref>). Both men and women, except for an insignificant difference in AUCs among indices of AIP, CMI, and LAP (<italic toggle="yes">P</italic> values&#8201;&gt;&#8201;0.05), showed significant differences in AUCs among other pairwise indices (<italic toggle="yes">P</italic> values&#8201;&lt;&#8201;0.001). Overall, men and women with a BMI&#8201;&lt;&#8201;25 kg/m<sup>2</sup> or aged&#8201;&lt;&#8201;50 years demonstrated higher AUCs for T2DM risk models than those with a BMI&#8201;&#8805;&#8201;25 kg/m<sup>2</sup> or aged&#8201;&#8805;&#8201;50 years. The difference in the discriminant ability of indices by age groups was more pronounced in men (Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Table&#160;S4).<fig id="Fig2" position="float" orientation="portrait"><label>Fig.&#160;2</label><caption><p>AUCs for models predicting T2DM risk using obesity indices. The same alphabets indicate insignificant difference (<italic toggle="yes">P</italic> values&#8201;&gt;&#8201;0.05), while different alphabets indicate significant difference in any pairwise indices&#8217; AUC (<italic toggle="yes">P</italic> values&#8201;&lt;&#8201;0.001). Log transformation was applied to CMI, LAP, Mets-IR, and VAI. AIP, atherogenic index of plasma; AUC, areas under the receiver operating characteristic curve; CMI, cardiometabolic index; HR, hazard ratio; LAP, lipid accumulation product; Mets-IR, metabolic score for insulin resistance; T2DM, type 2 diabetes mellitus; TyG, triglyceride-glucose index; VAI, visceral adiposity index. Models were adjusted for age (continue), smoking (no/yes), alcohol drinking (almost no/occasional/every day), hypertension drug therapy (no/yes), hyperlipidemia drug therapy (no/yes), systolic blood pressure (mmHg), diastolic blood pressure (mmHg), fast plasma glucose (mg/dL), body mass index (kg/m<sup>2</sup>), waist circumference (cm), high-density lipoprotein cholesterol (mg/dL), and low-density lipoprotein cholesterol (mg/dL). The adjustment excluded those already included in the index formula in each model</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="13098_2025_1795_Fig2_HTML.jpg"/></fig><table-wrap id="Tab5" position="float" orientation="portrait"><label>Table 5</label><caption><p>Diagnostic and predictive performance of obesity indices for type 2 diabetes mellitus incidence risk</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Index</th><th align="left" colspan="1" rowspan="1">AUC</th><th align="left" colspan="2" rowspan="1">95% CI</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> value difference</th><th align="left" colspan="1" rowspan="1">Cut-off value</th><th align="left" colspan="2" rowspan="1">95% CI</th><th align="left" colspan="1" rowspan="1">IDI</th><th align="left" colspan="2" rowspan="1">95% CI</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> value difference</th><th align="left" colspan="1" rowspan="1">NRI</th><th align="left" colspan="2" rowspan="1">95% CI</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> value difference</th></tr><tr><th align="left" colspan="16" rowspan="1"><italic toggle="yes">Men</italic></th></tr><tr><th align="left" colspan="1" rowspan="1">AIP</th><th align="left" colspan="1" rowspan="1">0.838</th><th align="left" colspan="1" rowspan="1">(0.830,</th><th align="left" colspan="1" rowspan="1">0.845)</th><th align="left" colspan="1" rowspan="1">&#8211;</th><th align="left" colspan="1" rowspan="1">0.72</th><th align="left" colspan="1" rowspan="1">(&#8722;&#8201;0.15,</th><th align="left" colspan="1" rowspan="1">1.60)</th><th align="left" colspan="1" rowspan="1">Ref</th><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">&#8211;</th><th align="left" colspan="1" rowspan="1">Ref</th><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">&#8211;</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">CMI</td><td char="." align="char" colspan="1" rowspan="1">0.837</td><td align="left" colspan="1" rowspan="1">(0.830,</td><td char="." align="char" colspan="1" rowspan="1">0.844)</td><td align="left" colspan="1" rowspan="1">0.059</td><td char="." align="char" colspan="1" rowspan="1">1.51</td><td align="left" colspan="1" rowspan="1">(0.54,</td><td char="." align="char" colspan="1" rowspan="1">2.48)</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0006</td><td align="left" colspan="1" rowspan="1">(&#8722;&#8201;0.0011,</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0002)</td><td align="left" colspan="1" rowspan="1">0.004</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0031</td><td align="left" colspan="1" rowspan="1">(&#8722;&#8201;0.0106,</td><td char="." align="char" colspan="1" rowspan="1">0.0043)</td><td align="left" colspan="1" rowspan="1">0.409</td></tr><tr><td align="left" colspan="1" rowspan="1">LAP</td><td char="." align="char" colspan="1" rowspan="1">0.837</td><td align="left" colspan="1" rowspan="1">(0.830,</td><td char="." align="char" colspan="1" rowspan="1">0.844)</td><td align="left" colspan="1" rowspan="1">0.058</td><td char="." align="char" colspan="1" rowspan="1">291.96</td><td align="left" colspan="1" rowspan="1">(84.64,</td><td char="." align="char" colspan="1" rowspan="1">499.28)</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0005</td><td align="left" colspan="1" rowspan="1">(&#8722;&#8201;0.0009,</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0001)</td><td align="left" colspan="1" rowspan="1">0.014</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0005</td><td align="left" colspan="1" rowspan="1">(&#8722;&#8201;0.0073,</td><td char="." align="char" colspan="1" rowspan="1">0.0063)</td><td align="left" colspan="1" rowspan="1">0.894</td></tr><tr><td align="left" colspan="1" rowspan="1">Mets-IR</td><td char="." align="char" colspan="1" rowspan="1">0.756</td><td align="left" colspan="1" rowspan="1">(0.748,</td><td char="." align="char" colspan="1" rowspan="1">0.765)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td char="." align="char" colspan="1" rowspan="1">39.98</td><td align="left" colspan="1" rowspan="1">(37.58,</td><td char="." align="char" colspan="1" rowspan="1">42.37)</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0571</td><td align="left" colspan="1" rowspan="1">(&#8722;&#8201;0.0606,</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0537)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.2675</td><td align="left" colspan="1" rowspan="1">(&#8722;&#8201;0.2875,</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.2475)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">TyG</td><td char="." align="char" colspan="1" rowspan="1">0.761</td><td align="left" colspan="1" rowspan="1">(0.753,</td><td char="." align="char" colspan="1" rowspan="1">0.769)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td char="." align="char" colspan="1" rowspan="1">8.52</td><td align="left" colspan="1" rowspan="1">(7.94,</td><td char="." align="char" colspan="1" rowspan="1">9.11)</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0555</td><td align="left" colspan="1" rowspan="1">(&#8722;&#8201;0.0589,</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0521)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.2677</td><td align="left" colspan="1" rowspan="1">(&#8722;&#8201;0.2879,</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.2474)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">VAI</td><td char="." align="char" colspan="1" rowspan="1">0.821</td><td align="left" colspan="1" rowspan="1">(0.813,</td><td char="." align="char" colspan="1" rowspan="1">0.828)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td char="." align="char" colspan="1" rowspan="1">3.62</td><td align="left" colspan="1" rowspan="1">(2.18,</td><td char="." align="char" colspan="1" rowspan="1">5.06)</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0140</td><td align="left" colspan="1" rowspan="1">(&#8722;&#8201;0.0163,</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0118)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0557</td><td align="left" colspan="1" rowspan="1">(&#8722;&#8201;0.0717,</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0397)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td></tr><tr><td align="left" colspan="16" rowspan="1"><italic toggle="yes">Women</italic></td></tr><tr><td align="left" colspan="1" rowspan="1">AIP</td><td char="." align="char" colspan="1" rowspan="1">0.844</td><td align="left" colspan="1" rowspan="1">(0.835,</td><td char="." align="char" colspan="1" rowspan="1">0.853)</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;</td><td char="." align="char" colspan="1" rowspan="1">0.39</td><td align="left" colspan="1" rowspan="1">(0.05,</td><td char="." align="char" colspan="1" rowspan="1">0.72)</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;</td><td align="left" colspan="1" rowspan="1">Ref</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;</td></tr><tr><td align="left" colspan="1" rowspan="1">CMI</td><td char="." align="char" colspan="1" rowspan="1">0.844</td><td align="left" colspan="1" rowspan="1">(0.835,</td><td char="." align="char" colspan="1" rowspan="1">0.853)</td><td align="left" colspan="1" rowspan="1">0.354</td><td char="." align="char" colspan="1" rowspan="1">0.63</td><td align="left" colspan="1" rowspan="1">(0.39,</td><td char="." align="char" colspan="1" rowspan="1">0.87)</td><td align="left" colspan="1" rowspan="1">0.0001</td><td align="left" colspan="1" rowspan="1">(&#8722;&#8201;0.0000,</td><td align="left" colspan="1" rowspan="1">0.0002)</td><td align="left" colspan="1" rowspan="1">0.112</td><td align="left" colspan="1" rowspan="1">0.0018</td><td align="left" colspan="1" rowspan="1">(&#8722;&#8201;0.0027,</td><td char="." align="char" colspan="1" rowspan="1">0.0063)</td><td align="left" colspan="1" rowspan="1">0.412</td></tr><tr><td align="left" colspan="1" rowspan="1">LAP</td><td char="." align="char" colspan="1" rowspan="1">0.843</td><td align="left" colspan="1" rowspan="1">(0.834,</td><td char="." align="char" colspan="1" rowspan="1">0.852)</td><td align="left" colspan="1" rowspan="1">0.534</td><td char="." align="char" colspan="1" rowspan="1">241.23</td><td align="left" colspan="1" rowspan="1">(&#8722;&#8201;104.69,</td><td char="." align="char" colspan="1" rowspan="1">587.16)</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0004</td><td align="left" colspan="1" rowspan="1">(&#8722;&#8201;0.0007,</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0001)</td><td align="left" colspan="1" rowspan="1">0.012</td><td align="left" colspan="1" rowspan="1">0.0028</td><td align="left" colspan="1" rowspan="1">(&#8722;&#8201;0.0034,</td><td char="." align="char" colspan="1" rowspan="1">0.0089)</td><td align="left" colspan="1" rowspan="1">0.381</td></tr><tr><td align="left" colspan="1" rowspan="1">Mets-IR</td><td char="." align="char" colspan="1" rowspan="1">0.771</td><td align="left" colspan="1" rowspan="1">(0.761,</td><td char="." align="char" colspan="1" rowspan="1">0.781)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td char="." align="char" colspan="1" rowspan="1">34.28</td><td align="left" colspan="1" rowspan="1">(28.65,</td><td char="." align="char" colspan="1" rowspan="1">39.92)</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0503</td><td align="left" colspan="1" rowspan="1">(&#8722;&#8201;0.0542,</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0464)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.2429</td><td align="left" colspan="1" rowspan="1">(&#8722;&#8201;0.2642,</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.2215)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">TyG</td><td char="." align="char" colspan="1" rowspan="1">0.780</td><td align="left" colspan="1" rowspan="1">(0.771,</td><td char="." align="char" colspan="1" rowspan="1">0.790)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td char="." align="char" colspan="1" rowspan="1">8.52</td><td align="left" colspan="1" rowspan="1">(8.26</td><td char="." align="char" colspan="1" rowspan="1">8.78)</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0471</td><td align="left" colspan="1" rowspan="1">(&#8722;&#8201;0.0507,</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0434)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.2317</td><td align="left" colspan="1" rowspan="1">(&#8722;&#8201;0.2539,</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.2095)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">VAI</td><td char="." align="char" colspan="1" rowspan="1">0.834</td><td align="left" colspan="1" rowspan="1">(0.825,</td><td char="." align="char" colspan="1" rowspan="1">0.843)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td char="." align="char" colspan="1" rowspan="1">3.80</td><td align="left" colspan="1" rowspan="1">(0.96,</td><td char="." align="char" colspan="1" rowspan="1">6.65)</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0069</td><td align="left" colspan="1" rowspan="1">(&#8722;&#8201;0.0089,</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0050)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;.0001</td><td align="left" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0234</td><td align="left" colspan="1" rowspan="1">(&#8722;&#8201;0.0392,</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&#8722;&#8201;0.0076)</td><td align="left" colspan="1" rowspan="1">0.004</td></tr></tbody></table><table-wrap-foot><p>AUC, area under the receiver operating characteristic curve; IDI, integrated discrimination improvement; NRI, net reclassification improvement; AIP, atherogenic index of plasma; AUC, area under the receiver operating curve; CI, confidence interval; CMI, cardiometabolic index; LAP, lipid accumulation product; Mets-IR, metabolic score for insulin resistance; TyG, triglyceride-glucose index; VAI, visceral adiposity index</p><p>Models were adjusted for age (year), body mass index (kg/m<sup>2</sup>), waist circumference (cm), smoking status (no/yes), alcohol drinking frequency (almost no/occasional/every day), hypertension drug therapy (no/yes), hyperlipidemia drug therapy (no/yes), systolic blood pressure (mmHg), diastolic blood pressure (mmHg), fasting plasma glucose (mg/dL), high-density lipoprotein cholesterol (mg/dL), and low-density lipoprotein cholesterol (mg/dL). Models for each index are adjusted without those already included in the index</p></table-wrap-foot></table-wrap></p><p id="Par46">Compared to the AIP model, a significantly lower IDI was observed for other indices, with the exception of CMI in females. Similar to the differences among AUCs, a significantly lower NRI was observed for Mets-IR, TyG, and VAI, and similar to CMI and LAP compared to AIP. The cut-off of the diagnostic value corresponding to the Youden index was similar for TyG and VAI in both sexes and relatively higher for AIP, CMI, LAP, and Mets-IR in males than in females.</p><p id="Par47">Dose&#8211;response relationships for T2DM risk (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig.&#160;S1A and Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Fig S1B), consistent with Cox regression, showed significant associations after the second knot for all indices, notably logMets-IR (both sexes) and TyG (women); nonlinear associations were significant for all indices in men, but only logCMI, logMets-IR, and TyG in women.</p></sec><sec id="Sec9"><title>Discussion</title><p id="Par48">Obesity indices are comprehensive measurements that show strong positive associations with T2DM incidence risk. The AIP, CMI, and LAP indices showed better diagnostic and predictive performances than Mets-IR, TyG, and VAI in both sexes.</p><p id="Par49">Diabetes remains a significant public health challenge in Japan. In addition to FPG, hemoglobin A1c and anthropometric measurements, diabetes screening tools with more context-specific and objective for early T2DM diagnosis are needed [<xref ref-type="bibr" rid="CR6">6</xref>]. To our knowledge, this is the first study to compare obesity surrogate markers associated with T2DM risk based on insurance information, including the initial AIP estimation, in a large Japanese population. This study adds evidence on the use of combined lipid profiles in identifying the T2DM incidence risk by utilizing a health insurance database. Furthermore, evaluating the diagnostic and predictive capabilities of these indices may provide insights for developing simple prediction tools, including the cut-off values for risk assessment.</p><p id="Par50">Excess fat accumulation contributes to T2DM development, particularly abdominal or central adiposity, in Asian populations, and T2DM onset occurs at a relatively young age and with a low BMI [<xref ref-type="bibr" rid="CR41">41</xref>]. Insulin resistance (IR) is a lack of physiological response to insulin, which acts on peripheral tissues and reduces glucose utilization in muscles and fats. It increases gluconeogenesis in the liver, leading to metabolic and hemodynamic disturbances, metabolic syndrome [<xref ref-type="bibr" rid="CR21">21</xref>], and diabetes [<xref ref-type="bibr" rid="CR42">42</xref>]. Obesity indices used in this study were simple and clinically useful insulin resistance surrogate markers [<xref ref-type="bibr" rid="CR21">21</xref>].</p><p id="Par51">BMI, as a common obesity marker, can be used to measure lipid accumulation but might not completely represent abnormal adipose tissue deposition, as it is unable to distinguish muscle mass from fat mass [<xref ref-type="bibr" rid="CR43">43</xref>]. LAP, TyG, and VAI have been introduced as indicators of &#8216;visceral adipose function&#8217; and insulin resistance. AIP is the product of TG and HDL-C, and CMI is the product of the waist-to-height ratio and TG/HDL-C. Both can determine cardiometabolic disease risk and T2DM [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. LAP represents increased lipotoxicity [<xref ref-type="bibr" rid="CR42">42</xref>] and is a better predictor of metabolic syndrome than BMI or WC, with the highest predictive accuracy [<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par52">FPG is a confirmatory plasma venous determinant of diabetes and is the mainstream screening index [<xref ref-type="bibr" rid="CR6">6</xref>]. We used FPG for adjustment in the analysis and significant associations were found for AIP, CMI, LAP, and VAI. Mets-IR and TyG are derived from FPG indices and are integrated indicators of insulin resistance and metabolic dysfunction. This may partially explain the stronger associations for Mets-IR and TyG than for the other index in both sexes in this study. The simplicity of these indices, based on routine clinical tests, makes them promising screening tools for diabetes [<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par53">Studies in diverse populations with varying genetic backgrounds have observed consistent associations between obesity indices and diabetes risk [<xref ref-type="bibr" rid="CR6">6</xref>], e.g., in American [<xref ref-type="bibr" rid="CR21">21</xref>], European [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR15">15</xref>], and Asian [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR24">24</xref>&#8211;<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR46">46</xref>] populations. The positive associations were also consistent with Japanese studies on LAP [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR46">46</xref>], CMI [<xref ref-type="bibr" rid="CR47">47</xref>], Mets-IR [<xref ref-type="bibr" rid="CR29">29</xref>], TyG [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>], and VAI [<xref ref-type="bibr" rid="CR28">28</xref>]. In our study, TyG and VAI values were similar to those in Thai [<xref ref-type="bibr" rid="CR14">14</xref>], Chinese [<xref ref-type="bibr" rid="CR20">20</xref>], and American [<xref ref-type="bibr" rid="CR21">21</xref>] populations; Mets-IR was lower than in Thai [<xref ref-type="bibr" rid="CR14">14</xref>] and Indonesian [<xref ref-type="bibr" rid="CR23">23</xref>] populations; and AIP, LAP, and VAI were higher than in Thai [<xref ref-type="bibr" rid="CR14">14</xref>], Chinese [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR20">20</xref>], American [<xref ref-type="bibr" rid="CR21">21</xref>], and Dutch [<xref ref-type="bibr" rid="CR40">40</xref>] populations.</p><p id="Par54">For Japanese populations, Wakabayashi et al. reported LAP values of 20.9 for males and 11.4 for females aged 35&#8211;40 years [<xref ref-type="bibr" rid="CR27">27</xref>], and 23.9 overall for those aged 35&#8211;60 years [<xref ref-type="bibr" rid="CR48">48</xref>]. The NAGALA study found LAP at 13.6 for males and 6.65 for females [<xref ref-type="bibr" rid="CR46">46</xref>], with mean TyG at 7.91 [<xref ref-type="bibr" rid="CR30">30</xref>]. Our study had higher LAP and VAI values than the NAGALA study [<xref ref-type="bibr" rid="CR28">28</xref>]. In the above index values, TyG was similar in the Japanese and other populations; however, LAP in our study was higher than that in others, which requires further study. The high LAP level may reflect the high overweight/obesity and lifestyle-related risk among Fukushima residents, who ranked worst in the country [<xref ref-type="bibr" rid="CR38">38</xref>].</p><p id="Par55">Our findings suggest that novel combined indices were overall stronger risk markers of T2DM, particularly in females [<xref ref-type="bibr" rid="CR24">24</xref>] and both sexes with a BMI&#8201;&lt;&#8201;25 kg/m<sup>2</sup> or aged&#8201;&lt;&#8201;50 years. This may be due to the higher lifestyle-related risk and anthropometric and laboratory measures in males than in females, resulting in higher LAP, TyG, and VAI [<xref ref-type="bibr" rid="CR40">40</xref>]. A Japanese study observed a J-shaped relationship between alcohol consumption and LAP, which was modified by smoking and exercise; however, alcohol consumption did not change the relationship between LAP and hyperglycemia [<xref ref-type="bibr" rid="CR48">48</xref>]. In the FDB group, we did not observe a significant association between physical activity, exercise, and T2DM in men and women. The insignificant association of LAP in Q4 vs. Q1 in overweight/obese women might be due to the lower proportion of obesity in women (21.8%). The insignificant nonlinear relationships in LAP in women may support this finding. The TyG index was more likely to be higher in concurrent smokers and alcohol consumers [<xref ref-type="bibr" rid="CR49">49</xref>]. The complexity and disparity in risk factors between males and females highlight the need for further studies on T2DM risk.</p><p id="Par56">The diagnostic performance of indices in our study, adjusted for covariates including blood plasma glucose, was similar to that of Chinese studies for LAP and VAI [<xref ref-type="bibr" rid="CR20">20</xref>]. It was higher than other studies for TyG [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR24">24</xref>], Mets-IR [<xref ref-type="bibr" rid="CR14">14</xref>], LAP [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR18">18</xref>], and VAI [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Referring to the AIP model with the highest AUC, the same predictive ability was observed for CMI and LAP; however, inferior performance was observed for Mets-IR, TyG, and VAI. This finding indicates that AIP, CMI, and LAP may be prominent predictors of T2DM risk in young and middle-aged Japanese. Although tests of NRI and IDI have been shown to have inflated false-positive rates [<xref ref-type="bibr" rid="CR50">50</xref>], this study was not designed to develop risk prediction models but rather to assess the discriminant ability of these indices. Nevertheless, although we explored indices&#8217; discriminant ability, given point estimation of cut-off values with confidence intervals, which could be elucidated differently across different study populations [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Further evidence, including studies in clinical settings for calibration, is needed, particularly regarding the accuracy and applicability necessary to evaluate if used further for clinical guidance. Recent work using continuous glucose monitoring dynamics has introduced novel markers for detecting diabetes onset and tracking disease progression, complementing traditional obesity-related indices [<xref ref-type="bibr" rid="CR51">51</xref>]. Additionally, machine learning models have been explored in other diabetes contexts, such as predicting diabetic retinopathy, demonstrating the broader potential of data-driven tools for early risk identification [<xref ref-type="bibr" rid="CR52">52</xref>].</p><p id="Par57">The strength of this study was that it included a large population with a higher proportion of annual health checkup attendance; thus, the study results may be generalized to other populations. The associations were measured through an identified cohort over more than 4 years of follow-up, showing similar significant results in the sensitivity analysis. Multiple imputations were performed for missing data, showing similar results to the complete case analysis and providing point and sensitive estimates of cut-off values for indices of T2DM risk. Nevertheless, for health promotion purposes, the study findings will be helpful for counseling and early identification of T2DM for clinicians and public health practitioners. Moreover, insurance databases with obesity indices can serve as surveillance tools for monitoring individual lifestyle improvements.</p><p id="Par58">However, this study had limitations. First, is that due to the availability of measurements in health checkups, we could not study and compare indices such as hip index, body adiposity index, and body fat percentage. Second, we only computed the baseline indices and could not clarify whether they affected the associations measured over the years [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Third, socioeconomic factors, such as educational level, family history of T2DM [<xref ref-type="bibr" rid="CR18">18</xref>], family income [<xref ref-type="bibr" rid="CR1">1</xref>], and occupation [<xref ref-type="bibr" rid="CR53">53</xref>], which were significant determinants of lifestyle and health literacy in diabetes, were not available for adjustment in the regression analysis [<xref ref-type="bibr" rid="CR1">1</xref>]. This study may have overestimated the associations between the obesity indices and T2DM risk due to the absence of these covariates. Future studies developing models predicting T2DM risk using these indices may require additional covariates. In addition, LAP calculations were based on examinations in Western countries, which may need to be updated for the Japanese population.</p><p id="Par59">In summary, this study underscores the value of using multiple obesity indices, rather than relying on a single health metric, to predict T2DM incidence risk among young and middle-aged Japanese individuals. This study provides clinically relevant information on the value of obesity indices in predicting T2DM risk in the general population. In particular, referring to the cut-off values of AIP, CMI, and LAP, may assist in estimating T2DM risk. Indices based on routine clinical tests may help in a primary care setting to identify high-risk individuals, for early diagnosis, or for the evaluation of complications in patients with diabetes. However, to validate our findings further, repeated studies for designing, developing, and implementing better diabetes screening tools in standard approaches for the assessment, monitoring, and education in communities or among individuals for prevention of T2DM are needed.</p></sec><sec id="Sec10" sec-type="supplementary-material"><title>Supplementary Information</title><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13098_2025_1795_MOESM1_ESM.pdf" position="float" orientation="portrait"><caption><p>Additional file 1: Figure. S1A Dose-response relationships of obesity indices and type 2 diabetes mellitus incidence risk in men.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13098_2025_1795_MOESM2_ESM.pdf" position="float" orientation="portrait"><caption><p>Additional file 2: Figure. S1B Dose-response relationships of obesity indices and type 2 diabetes mellitus incidence risk in women).</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM3" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13098_2025_1795_MOESM3_ESM.docx" position="float" orientation="portrait"><caption><p>Additional file 3.</p></caption></media></supplementary-material></p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>AIP</term><def><p id="Par5">Atherogenic index of plasma</p></def></def-item><def-item><term>AUC</term><def><p id="Par6">Area under the receiver operating characteristic curve</p></def></def-item><def-item><term>BMI</term><def><p id="Par7">Body mass index (kg/m<sup>2</sup>)</p></def></def-item><def-item><term>CMI</term><def><p id="Par8">Cardiometabolic index</p></def></def-item><def-item><term>FDB</term><def><p id="Par9">Fukushima Health Database</p></def></def-item><def-item><term>FPG</term><def><p id="Par10">Fasting plasma glucose</p></def></def-item><def-item><term>HDL-C</term><def><p id="Par11">High-density lipoprotein cholesterol</p></def></def-item><def-item><term>IDI</term><def><p id="Par12">Integrated discrimination improvement</p></def></def-item><def-item><term>LAP</term><def><p id="Par13">Lipid accumulation product</p></def></def-item><def-item><term>LDL-C</term><def><p id="Par14">Low-density lipoprotein cholesterol</p></def></def-item><def-item><term>Mets-IR</term><def><p id="Par15">Metabolic score for insulin resistance</p></def></def-item><def-item><term>NRI</term><def><p id="Par16">Net reclassification improvement</p></def></def-item><def-item><term>RCS</term><def><p id="Par17">Restricted cubic spline</p></def></def-item><def-item><term>T2DM</term><def><p id="Par18">Type 2 diabetes mellitus</p></def></def-item><def-item><term>TG</term><def><p id="Par19">Triglycerides</p></def></def-item><def-item><term>TyG</term><def><p id="Par20">Triglyceride-glucose</p></def></def-item><def-item><term>VAI</term><def><p id="Par21">Visceral adiposity index</p></def></def-item><def-item><term>VIF</term><def><p id="Par22">Variance inflation factor</p></def></def-item><def-item><term>WC</term><def><p id="Par23">Waist circumference</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors are grateful to the Health Promotion Department, Fukushima Prefecture Health Authority, for the administration effort, the National Insurance Association, and the Kyoukai Kenpo Fukushima Branch for providing the data.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>E.M. analyzed data and drafted the manuscript; T.O., M.F., A.S., K.M., M.H., S.Y., and M.S. reviewed and edited the manuscript; A.S. prepared datasets; and T.O. verified the data analysis. All authors read and approved the final version of the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This study was supported by a consignment fee from the Fukushima Prefectural Government.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>The datasets generated and/or analyzed during the current study are not publicly available because of confidentiality but are available from the corresponding author upon reasonable request and approval from the Fukushima Government.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par60">This study was approved by the Fukushima Medical University Ethical Review Committee (Generic 2021&#8211;169). The study was conducted using secondary administrative data accumulated in the database, with personal information anonymised. Thus, informed consent was not obtained from participants.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par61">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par62">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>JCN</given-names></name><name name-style="western"><surname>Lim</surname><given-names>LL</given-names></name><name name-style="western"><surname>Wareham</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Shaw</surname><given-names>JE</given-names></name><name name-style="western"><surname>Orchard</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P</given-names></name><etal/></person-group><article-title>The lancet commission on diabetes: using data to transform diabetes care and patient lives</article-title><source>Lancet</source><year>2021</year><volume>396</volume><fpage>2019</fpage><lpage>2082</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)32374-6</pub-id><pub-id pub-id-type="pmid">33189186</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Chan JCN, Lim LL, Wareham NJ, Shaw JE, Orchard TJ, Zhang P, et al. The lancet commission on diabetes: using data to transform diabetes care and patient lives. Lancet. 2021;396:2019&#8211;82. 10.1016/S0140-6736(20)32374-6.<pub-id pub-id-type="pmid">33189186</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(20)32374-6</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knowler</surname><given-names>WC</given-names></name><name name-style="western"><surname>Barrett-Connor</surname><given-names>E</given-names></name><name name-style="western"><surname>Fowler</surname><given-names>SE</given-names></name><name name-style="western"><surname>Hamman</surname><given-names>RF</given-names></name><name name-style="western"><surname>Lachin</surname><given-names>JM</given-names></name><name name-style="western"><surname>Walker</surname><given-names>EA</given-names></name><etal/></person-group><article-title>Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin</article-title><source>N Engl J Med</source><year>2002</year><volume>346</volume><fpage>393</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa012512</pub-id><pub-id pub-id-type="pmid">11832527</pub-id><pub-id pub-id-type="pmcid">PMC1370926</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393&#8211;403. 10.1056/NEJMoa012512.<pub-id pub-id-type="pmid">11832527</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa012512</pub-id><pub-id pub-id-type="pmcid">PMC1370926</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahn</surname><given-names>N</given-names></name><name name-style="western"><surname>Baumeister</surname><given-names>SE</given-names></name><name name-style="western"><surname>Amann</surname><given-names>U</given-names></name><name name-style="western"><surname>Rathmann</surname><given-names>W</given-names></name><name name-style="western"><surname>Peters</surname><given-names>A</given-names></name><name name-style="western"><surname>Huth</surname><given-names>C</given-names></name><etal/></person-group><article-title>Visceral adiposity index (VAI), lipid accumulation product (LAP), and product of triglycerides and glucose (TyG) to discriminate prediabetes and diabetes</article-title><source>Sci Rep</source><year>2019</year><volume>9</volume><fpage>9693</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-46187-8</pub-id><pub-id pub-id-type="pmid">31273286</pub-id><pub-id pub-id-type="pmcid">PMC6609728</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Ahn N, Baumeister SE, Amann U, Rathmann W, Peters A, Huth C, et al. Visceral adiposity index (VAI), lipid accumulation product (LAP), and product of triglycerides and glucose (TyG) to discriminate prediabetes and diabetes. Sci Rep. 2019;9:9693. 10.1038/s41598-019-46187-8.<pub-id pub-id-type="pmid">31273286</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-019-46187-8</pub-id><pub-id pub-id-type="pmcid">PMC6609728</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sun</surname><given-names>G</given-names></name><name name-style="western"><surname>Jia</surname><given-names>P</given-names></name><name name-style="western"><surname>Qian</surname><given-names>H</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name></person-group><article-title>Validity of cardiometabolic index, lipid accumulation product, and body adiposity index in predicting the risk of hypertension in Chinese population</article-title><source>Postgrad Med</source><year>2018</year><volume>130</volume><fpage>325</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1080/00325481.2018.1444901</pub-id><pub-id pub-id-type="pmid">29478365</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Wang H, Chen Y, Sun G, Jia P, Qian H, Sun Y. Validity of cardiometabolic index, lipid accumulation product, and body adiposity index in predicting the risk of hypertension in Chinese population. Postgrad Med. 2018;130:325&#8211;33. 10.1080/00325481.2018.1444901.<pub-id pub-id-type="pmid">29478365</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/00325481.2018.1444901</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parrinello</surname><given-names>CM</given-names></name><name name-style="western"><surname>Selvin</surname><given-names>E</given-names></name></person-group><article-title>Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management</article-title><source>Curr Diab Rep</source><year>2014</year><volume>14</volume><fpage>548</fpage><pub-id pub-id-type="doi">10.1007/s11892-014-0548-3</pub-id><pub-id pub-id-type="pmid">25249070</pub-id><pub-id pub-id-type="pmcid">PMC4214073</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Parrinello CM, Selvin E. Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management. Curr Diab Rep. 2014;14:548. 10.1007/s11892-014-0548-3.<pub-id pub-id-type="pmid">25249070</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11892-014-0548-3</pub-id><pub-id pub-id-type="pmcid">PMC4214073</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simmons</surname><given-names>SS</given-names></name></person-group><article-title>Strikes and gutters: biomarkers and anthropometric measures for predicting diagnosed diabetes mellitus in adults in low- and middle-income countries</article-title><source>Heliyon</source><year>2023</year><volume>9</volume><fpage>e19494</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2023.e19494</pub-id><pub-id pub-id-type="pmid">37810094</pub-id><pub-id pub-id-type="pmcid">PMC10558610</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Simmons SS. Strikes and gutters: biomarkers and anthropometric measures for predicting diagnosed diabetes mellitus in adults in low- and middle-income countries. Heliyon. 2023;9: e19494. 10.1016/j.heliyon.2023.e19494.<pub-id pub-id-type="pmid">37810094</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.heliyon.2023.e19494</pub-id><pub-id pub-id-type="pmcid">PMC10558610</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>N</given-names></name><name name-style="western"><surname>Kamishima</surname><given-names>T</given-names></name><name name-style="western"><surname>Jia</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>D</given-names></name><name name-style="western"><surname>Hind</surname><given-names>K</given-names></name><etal/></person-group><article-title>Visceral obesity and lipid profiles in chinese adults with normal and high body mass index</article-title><source>Diagnostics (Basel).</source><year>2022</year><pub-id pub-id-type="doi">10.3390/diagnostics12102522</pub-id><pub-id pub-id-type="pmid">36292210</pub-id><pub-id pub-id-type="pmcid">PMC9600752</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Lu Y, Li N, Kamishima T, Jia P, Zhou D, Hind K, et al. Visceral obesity and lipid profiles in chinese adults with normal and high body mass index. Diagnostics (Basel). 2022. 10.3390/diagnostics12102522.<pub-id pub-id-type="pmid">36292210</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/diagnostics12102522</pub-id><pub-id pub-id-type="pmcid">PMC9600752</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wander</surname><given-names>PL</given-names></name><name name-style="western"><surname>Hayashi</surname><given-names>T</given-names></name><name name-style="western"><surname>Sato</surname><given-names>KK</given-names></name><name name-style="western"><surname>Uehara</surname><given-names>S</given-names></name><name name-style="western"><surname>Hikita</surname><given-names>Y</given-names></name><name name-style="western"><surname>Leonetti</surname><given-names>DL</given-names></name><etal/></person-group><article-title>Design and validation of a novel estimator of visceral adipose tissue area and comparison to existing adiposity surrogates</article-title><source>J Diabetes Compl</source><year>2018</year><volume>32</volume><fpage>1062</fpage><lpage>1067</lpage><pub-id pub-id-type="doi">10.1016/j.jdiacomp.2018.09.004</pub-id><pub-id pub-id-type="pmcid">PMC6174110</pub-id><pub-id pub-id-type="pmid">30236542</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Wander PL, Hayashi T, Sato KK, Uehara S, Hikita Y, Leonetti DL, et al. Design and validation of a novel estimator of visceral adipose tissue area and comparison to existing adiposity surrogates. J Diabetes Compl. 2018;32:1062&#8211;7. 10.1016/j.jdiacomp.2018.09.004.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jdiacomp.2018.09.004</pub-id><pub-id pub-id-type="pmcid">PMC6174110</pub-id><pub-id pub-id-type="pmid">30236542</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takami</surname><given-names>R</given-names></name><name name-style="western"><surname>Takeda</surname><given-names>N</given-names></name><name name-style="western"><surname>Hayashi</surname><given-names>M</given-names></name><name name-style="western"><surname>Sasaki</surname><given-names>A</given-names></name><name name-style="western"><surname>Kawachi</surname><given-names>S</given-names></name><name name-style="western"><surname>Yoshino</surname><given-names>K</given-names></name><etal/></person-group><article-title>Body fatness and fat distribution as predictors of metabolic abnormalities and early carotid atherosclerosis</article-title><source>Diabetes Care</source><year>2001</year><volume>24</volume><fpage>1248</fpage><lpage>1252</lpage><pub-id pub-id-type="doi">10.2337/diacare.24.7.1248</pub-id><pub-id pub-id-type="pmid">11423510</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Takami R, Takeda N, Hayashi M, Sasaki A, Kawachi S, Yoshino K, et al. Body fatness and fat distribution as predictors of metabolic abnormalities and early carotid atherosclerosis. Diabetes Care. 2001;24:1248&#8211;52. 10.2337/diacare.24.7.1248.<pub-id pub-id-type="pmid">11423510</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/diacare.24.7.1248</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakano</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kubota</surname><given-names>T</given-names></name><name name-style="western"><surname>Ohata</surname><given-names>Y</given-names></name><name name-style="western"><surname>Takeyari</surname><given-names>S</given-names></name><name name-style="western"><surname>Kitaoka</surname><given-names>T</given-names></name><name name-style="western"><surname>Miyoshi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Assessment of body fat mass, anthropometric measurement and cardiometabolic risk in children and adolescents with achondroplasia and hypochondroplasia</article-title><source>Endocr J</source><year>2023</year><volume>70</volume><fpage>435</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1507/endocrj.EJ22-0477</pub-id><pub-id pub-id-type="pmid">36740254</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Nakano Y, Kubota T, Ohata Y, Takeyari S, Kitaoka T, Miyoshi Y, et al. Assessment of body fat mass, anthropometric measurement and cardiometabolic risk in children and adolescents with achondroplasia and hypochondroplasia. Endocr J. 2023;70:435&#8211;43. 10.1507/endocrj.EJ22-0477.<pub-id pub-id-type="pmid">36740254</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1507/endocrj.EJ22-0477</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abolhasani</surname><given-names>M</given-names></name><name name-style="western"><surname>Maghbouli</surname><given-names>N</given-names></name><name name-style="western"><surname>Sazgara</surname><given-names>F</given-names></name><name name-style="western"><surname>Karbalai Saleh</surname><given-names>S</given-names></name><name name-style="western"><surname>Tahmasebi</surname><given-names>M</given-names></name><name name-style="western"><surname>Ashraf</surname><given-names>H</given-names></name></person-group><article-title>Evaluation of several anthropometric and metabolic indices as correlates of hyperglycemia in overweight/obese adults</article-title><source>Diabetes Metab Syndr Obes</source><year>2020</year><volume>13</volume><fpage>2327</fpage><lpage>2336</lpage><pub-id pub-id-type="doi">10.2147/DMSO.S254741</pub-id><pub-id pub-id-type="pmid">32753917</pub-id><pub-id pub-id-type="pmcid">PMC7342503</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Abolhasani M, Maghbouli N, Sazgara F, Karbalai Saleh S, Tahmasebi M, Ashraf H. Evaluation of several anthropometric and metabolic indices as correlates of hyperglycemia in overweight/obese adults. Diabetes Metab Syndr Obes. 2020;13:2327&#8211;36. 10.2147/DMSO.S254741.<pub-id pub-id-type="pmid">32753917</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/DMSO.S254741</pub-id><pub-id pub-id-type="pmcid">PMC7342503</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gomez-Ambrosi</surname><given-names>J</given-names></name><name name-style="western"><surname>Silva</surname><given-names>C</given-names></name><name name-style="western"><surname>Catalan</surname><given-names>V</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>A</given-names></name><name name-style="western"><surname>Galofre</surname><given-names>JC</given-names></name><name name-style="western"><surname>Escalada</surname><given-names>J</given-names></name><etal/></person-group><article-title>Clinical usefulness of a new equation for estimating body fat</article-title><source>Diabetes Care</source><year>2012</year><volume>35</volume><fpage>383</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.2337/dc11-1334</pub-id><pub-id pub-id-type="pmid">22179957</pub-id><pub-id pub-id-type="pmcid">PMC3263863</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Gomez-Ambrosi J, Silva C, Catalan V, Rodriguez A, Galofre JC, Escalada J, et al. Clinical usefulness of a new equation for estimating body fat. Diabetes Care. 2012;35:383&#8211;8. 10.2337/dc11-1334.<pub-id pub-id-type="pmid">22179957</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/dc11-1334</pub-id><pub-id pub-id-type="pmcid">PMC3263863</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ray</surname><given-names>L</given-names></name><name name-style="western"><surname>Ravichandran</surname><given-names>K</given-names></name><name name-style="western"><surname>Nanda</surname><given-names>SK</given-names></name></person-group><article-title>Comparison of lipid accumulation product index with body mass index and waist circumference as a predictor of metabolic syndrome in indian population</article-title><source>Metab Syndr Relat Disord</source><year>2018</year><volume>16</volume><fpage>240</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1089/met.2017.0119</pub-id><pub-id pub-id-type="pmid">29648916</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Ray L, Ravichandran K, Nanda SK. Comparison of lipid accumulation product index with body mass index and waist circumference as a predictor of metabolic syndrome in indian population. Metab Syndr Relat Disord. 2018;16:240&#8211;5. 10.1089/met.2017.0119.<pub-id pub-id-type="pmid">29648916</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/met.2017.0119</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rattanatham</surname><given-names>R</given-names></name><name name-style="western"><surname>Tangpong</surname><given-names>J</given-names></name><name name-style="western"><surname>Chatatikun</surname><given-names>M</given-names></name><name name-style="western"><surname>Sun</surname><given-names>D</given-names></name><name name-style="western"><surname>Kawakami</surname><given-names>F</given-names></name><name name-style="western"><surname>Imai</surname><given-names>M</given-names></name><etal/></person-group><article-title>Assessment of eight insulin resistance surrogate indexes for predicting metabolic syndrome and hypertension in Thai law enforcement officers</article-title><source>PeerJ</source><year>2023</year><volume>11</volume><fpage>e15463</fpage><pub-id pub-id-type="doi">10.7717/peerj.15463</pub-id><pub-id pub-id-type="pmid">37273533</pub-id><pub-id pub-id-type="pmcid">PMC10234272</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Rattanatham R, Tangpong J, Chatatikun M, Sun D, Kawakami F, Imai M, et al. Assessment of eight insulin resistance surrogate indexes for predicting metabolic syndrome and hypertension in Thai law enforcement officers. PeerJ. 2023;11: e15463. 10.7717/peerj.15463.<pub-id pub-id-type="pmid">37273533</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7717/peerj.15463</pub-id><pub-id pub-id-type="pmcid">PMC10234272</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klisic</surname><given-names>A</given-names></name><name name-style="western"><surname>Radoman Vujacic</surname><given-names>I</given-names></name><name name-style="western"><surname>Kostadinovic</surname><given-names>J</given-names></name><name name-style="western"><surname>Patoulias</surname><given-names>D</given-names></name><name name-style="western"><surname>Ninic</surname><given-names>A</given-names></name></person-group><article-title>Novel anthropometric parameters in the adult population with prediabetes</article-title><source>Eur Rev Med Pharmacol Sci</source><year>2023</year><volume>27</volume><fpage>11063</fpage><lpage>11072</lpage><pub-id pub-id-type="doi">10.26355/eurrev_202311_34475</pub-id><pub-id pub-id-type="pmid">38039037</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Klisic A, Radoman Vujacic I, Kostadinovic J, Patoulias D, Ninic A. Novel anthropometric parameters in the adult population with prediabetes. Eur Rev Med Pharmacol Sci. 2023;27:11063&#8211;72. 10.26355/eurrev_202311_34475.<pub-id pub-id-type="pmid">38039037</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.26355/eurrev_202311_34475</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mazidi</surname><given-names>M</given-names></name><name name-style="western"><surname>Kengne</surname><given-names>AP</given-names></name><name name-style="western"><surname>Katsiki</surname><given-names>N</given-names></name><name name-style="western"><surname>Mikhailidis</surname><given-names>DP</given-names></name><name name-style="western"><surname>Banach</surname><given-names>M</given-names></name></person-group><article-title>Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance</article-title><source>J Diabetes Complicat</source><year>2018</year><volume>32</volume><fpage>266</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1016/j.jdiacomp.2017.10.007</pub-id><pub-id pub-id-type="pmid">29395839</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Mazidi M, Kengne AP, Katsiki N, Mikhailidis DP, Banach M. Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance. J Diabetes Complicat. 2018;32:266&#8211;70. 10.1016/j.jdiacomp.2017.10.007.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jdiacomp.2017.10.007</pub-id><pub-id pub-id-type="pmid">29395839</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chiang</surname><given-names>JK</given-names></name><name name-style="western"><surname>Koo</surname><given-names>M</given-names></name></person-group><article-title>Lipid accumulation product: a simple and accurate index for predicting metabolic syndrome in Taiwanese people aged 50 and over</article-title><source>BMC Cardiovasc Disord</source><year>2012</year><volume>12</volume><fpage>78</fpage><pub-id pub-id-type="doi">10.1186/1471-2261-12-78</pub-id><pub-id pub-id-type="pmid">23006530</pub-id><pub-id pub-id-type="pmcid">PMC3506496</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Chiang JK, Koo M. Lipid accumulation product: a simple and accurate index for predicting metabolic syndrome in Taiwanese people aged 50 and over. BMC Cardiovasc Disord. 2012;12:78. 10.1186/1471-2261-12-78.<pub-id pub-id-type="pmid">23006530</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1471-2261-12-78</pub-id><pub-id pub-id-type="pmcid">PMC3506496</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>CY</given-names></name><name name-style="western"><surname>Li</surname><given-names>JB</given-names></name><name name-style="western"><surname>Wu</surname><given-names>F</given-names></name><name name-style="western"><surname>Wang</surname><given-names>JJ</given-names></name><name name-style="western"><surname>An</surname><given-names>HH</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>HN</given-names></name><etal/></person-group><article-title>Comparison of lipid accumulation product and visceral adiposity index with traditional obesity indices in early-onset type 2 diabetes prediction: a cross-sectional study</article-title><source>Diabetol Metab Syndr</source><year>2023</year><volume>15</volume><fpage>111</fpage><pub-id pub-id-type="doi">10.1186/s13098-023-01056-3</pub-id><pub-id pub-id-type="pmid">37237396</pub-id><pub-id pub-id-type="pmcid">PMC10223887</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Lin CY, Li JB, Wu F, Wang JJ, An HH, Qiu HN, et al. Comparison of lipid accumulation product and visceral adiposity index with traditional obesity indices in early-onset type 2 diabetes prediction: a cross-sectional study. Diabetol Metab Syndr. 2023;15:111. 10.1186/s13098-023-01056-3.<pub-id pub-id-type="pmid">37237396</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13098-023-01056-3</pub-id><pub-id pub-id-type="pmcid">PMC10223887</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>ZY</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhuang</surname><given-names>XX</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>YC</given-names></name><name name-style="western"><surname>Ma</surname><given-names>YN</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Lipid accumulation product is a better predictor of metabolic syndrome in Chinese adolescents: a cross-sectional study</article-title><source>Front Endocrinol (Lausanne)</source><year>2023</year><volume>14</volume><fpage>1179990</fpage><pub-id pub-id-type="doi">10.3389/fendo.2023.1179990</pub-id><pub-id pub-id-type="pmid">37424867</pub-id><pub-id pub-id-type="pmcid">PMC10326626</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Chen ZY, Liu L, Zhuang XX, Zhang YC, Ma YN, Liu Y, et al. Lipid accumulation product is a better predictor of metabolic syndrome in Chinese adolescents: a cross-sectional study. Front Endocrinol (Lausanne). 2023;14:1179990. 10.3389/fendo.2023.1179990.<pub-id pub-id-type="pmid">37424867</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fendo.2023.1179990</pub-id><pub-id pub-id-type="pmcid">PMC10326626</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gui</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Guo</surname><given-names>LL</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Lei</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Predicting metabolic syndrome by obesity- and lipid-related indices in mid-aged and elderly Chinese: a population-based cross-sectional study</article-title><source>Front Endocrinol (Lausanne)</source><year>2023</year><volume>14</volume><fpage>1201132</fpage><pub-id pub-id-type="doi">10.3389/fendo.2023.1201132</pub-id><pub-id pub-id-type="pmid">37576971</pub-id><pub-id pub-id-type="pmcid">PMC10419183</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Li Y, Gui J, Liu H, Guo LL, Li J, Lei Y, et al. Predicting metabolic syndrome by obesity- and lipid-related indices in mid-aged and elderly Chinese: a population-based cross-sectional study. Front Endocrinol (Lausanne). 2023;14:1201132. 10.3389/fendo.2023.1201132.<pub-id pub-id-type="pmid">37576971</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fendo.2023.1201132</pub-id><pub-id pub-id-type="pmcid">PMC10419183</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name><name name-style="western"><surname>Kim</surname><given-names>B</given-names></name><name name-style="western"><surname>Kim</surname><given-names>W</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>C</given-names></name><name name-style="western"><surname>Choi</surname><given-names>HY</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JG</given-names></name><etal/></person-group><article-title>Lipid indices as simple and clinically useful surrogate markers for insulin resistance in the U.S. population</article-title><source>Sci Rep</source><year>2021</year><volume>11</volume><fpage>2366</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-82053-2</pub-id><pub-id pub-id-type="pmid">33504930</pub-id><pub-id pub-id-type="pmcid">PMC7840900</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Lee J, Kim B, Kim W, Ahn C, Choi HY, Kim JG, et al. Lipid indices as simple and clinically useful surrogate markers for insulin resistance in the U.S. population. Sci Rep. 2021;11:2366. 10.1038/s41598-021-82053-2.<pub-id pub-id-type="pmid">33504930</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-021-82053-2</pub-id><pub-id pub-id-type="pmcid">PMC7840900</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>TL</given-names></name><name name-style="western"><surname>Liu</surname><given-names>YH</given-names></name><name name-style="western"><surname>Wu</surname><given-names>PY</given-names></name><name name-style="western"><surname>Huang</surname><given-names>JC</given-names></name><name name-style="western"><surname>Chen</surname><given-names>SC</given-names></name></person-group><article-title>Sex difference in the associations among obesity-related indices with incidence of diabetes mellitus in a large Taiwanese population follow-up study</article-title><source>Front Public Health</source><year>2023</year><volume>11</volume><fpage>1094471</fpage><pub-id pub-id-type="doi">10.3389/fpubh.2023.1094471</pub-id><pub-id pub-id-type="pmid">36741951</pub-id><pub-id pub-id-type="pmcid">PMC9895090</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Chung TL, Liu YH, Wu PY, Huang JC, Chen SC. Sex difference in the associations among obesity-related indices with incidence of diabetes mellitus in a large Taiwanese population follow-up study. Front Public Health. 2023;11:1094471. 10.3389/fpubh.2023.1094471.<pub-id pub-id-type="pmid">36741951</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fpubh.2023.1094471</pub-id><pub-id pub-id-type="pmcid">PMC9895090</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Widjaja</surname><given-names>NA</given-names></name><name name-style="western"><surname>Irawan</surname><given-names>R</given-names></name><name name-style="western"><surname>Hanindita</surname><given-names>MH</given-names></name><name name-style="western"><surname>Ugrasena</surname><given-names>I</given-names></name><name name-style="western"><surname>Handajani</surname><given-names>R</given-names></name></person-group><article-title>METS-IR vs HOMA-AD and metabolic syndrome in obese adolescents</article-title><source>J Med Invest</source><year>2023</year><volume>70</volume><fpage>7</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.2152/jmi.70.7</pub-id><pub-id pub-id-type="pmid">37164746</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Widjaja NA, Irawan R, Hanindita MH, Ugrasena I, Handajani R. METS-IR vs HOMA-AD and metabolic syndrome in obese adolescents. J Med Invest. 2023;70:7&#8211;16. 10.2152/jmi.70.7.<pub-id pub-id-type="pmid">37164746</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2152/jmi.70.7</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>B</given-names></name><name name-style="western"><surname>Taniguchi</surname><given-names>K</given-names></name><name name-style="western"><surname>Isobe</surname><given-names>T</given-names></name><name name-style="western"><surname>Oh</surname><given-names>S</given-names></name></person-group><article-title>Triglyceride-glucose index is capable of identifying metabolically obese, normal-weight older individuals</article-title><source>J Physiol Anthropol</source><year>2024</year><volume>43</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.1186/s40101-024-00355-6</pub-id><pub-id pub-id-type="pmid">38310267</pub-id><pub-id pub-id-type="pmcid">PMC10837892</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Kim B, Taniguchi K, Isobe T, Oh S. Triglyceride-glucose index is capable of identifying metabolically obese, normal-weight older individuals. J Physiol Anthropol. 2024;43:8. 10.1186/s40101-024-00355-6.<pub-id pub-id-type="pmid">38310267</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40101-024-00355-6</pub-id><pub-id pub-id-type="pmcid">PMC10837892</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>G</given-names></name><name name-style="western"><surname>Qu</surname><given-names>C</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Qian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>L</given-names></name><etal/></person-group><article-title>Predictive performance of lipid parameters in identifying undiagnosed diabetes and prediabetes: a cross-sectional study in eastern China</article-title><source>BMC Endocr Disord</source><year>2022</year><volume>22</volume><fpage>76</fpage><pub-id pub-id-type="doi">10.1186/s12902-022-00984-x</pub-id><pub-id pub-id-type="pmid">35331213</pub-id><pub-id pub-id-type="pmcid">PMC8952267</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Zhou Y, Yang G, Qu C, Chen J, Qian Y, Yuan L, et al. Predictive performance of lipid parameters in identifying undiagnosed diabetes and prediabetes: a cross-sectional study in eastern China. BMC Endocr Disord. 2022;22:76. 10.1186/s12902-022-00984-x.<pub-id pub-id-type="pmid">35331213</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12902-022-00984-x</pub-id><pub-id pub-id-type="pmcid">PMC8952267</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al Akl</surname><given-names>NS</given-names></name><name name-style="western"><surname>Haoudi</surname><given-names>EN</given-names></name><name name-style="western"><surname>Bensmail</surname><given-names>H</given-names></name><name name-style="western"><surname>Arredouani</surname><given-names>A</given-names></name></person-group><article-title>The triglyceride glucose-waist-to-height ratio outperforms obesity and other triglyceride-related parameters in detecting prediabetes in normal-weight Qatari adults: a cross-sectional study</article-title><source>Front Public Health</source><year>2023</year><volume>11</volume><fpage>1086771</fpage><pub-id pub-id-type="doi">10.3389/fpubh.2023.1086771</pub-id><pub-id pub-id-type="pmid">37089491</pub-id><pub-id pub-id-type="pmcid">PMC10117653</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Al Akl NS, Haoudi EN, Bensmail H, Arredouani A. The triglyceride glucose-waist-to-height ratio outperforms obesity and other triglyceride-related parameters in detecting prediabetes in normal-weight Qatari adults: a cross-sectional study. Front Public Health. 2023;11:1086771. 10.3389/fpubh.2023.1086771.<pub-id pub-id-type="pmid">37089491</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fpubh.2023.1086771</pub-id><pub-id pub-id-type="pmcid">PMC10117653</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wakabayashi</surname><given-names>I</given-names></name><name name-style="western"><surname>Daimon</surname><given-names>T</given-names></name></person-group><article-title>A strong association between lipid accumulation product and diabetes mellitus in Japanese women and men</article-title><source>J Atheroscler Thromb</source><year>2014</year><volume>21</volume><fpage>282</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.5551/jat.20628</pub-id><pub-id pub-id-type="pmid">24304961</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Wakabayashi I, Daimon T. A strong association between lipid accumulation product and diabetes mellitus in Japanese women and men. J Atheroscler Thromb. 2014;21:282&#8211;8. 10.5551/jat.20628.<pub-id pub-id-type="pmid">24304961</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5551/jat.20628</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>T</given-names></name><name name-style="western"><surname>Lu</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name><name name-style="western"><surname>Yao</surname><given-names>T</given-names></name><name name-style="western"><surname>Song</surname><given-names>B</given-names></name><name name-style="western"><surname>Fan</surname><given-names>H</given-names></name><etal/></person-group><article-title>Relationship between lipid accumulation product and new-onset diabetes in the Japanese population: a retrospective cohort study</article-title><source>Front Endocrinol (Lausanne)</source><year>2023</year><volume>14</volume><fpage>1181941</fpage><pub-id pub-id-type="doi">10.3389/fendo.2023.1181941</pub-id><pub-id pub-id-type="pmid">37265697</pub-id><pub-id pub-id-type="pmcid">PMC10230034</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Liu T, Lu W, Zhao X, Yao T, Song B, Fan H, et al. Relationship between lipid accumulation product and new-onset diabetes in the Japanese population: a retrospective cohort study. Front Endocrinol (Lausanne). 2023;14:1181941. 10.3389/fendo.2023.1181941.<pub-id pub-id-type="pmid">37265697</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fendo.2023.1181941</pub-id><pub-id pub-id-type="pmcid">PMC10230034</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shangguan</surname><given-names>Q</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yang</surname><given-names>R</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Sheng</surname><given-names>G</given-names></name><name name-style="western"><surname>Kuang</surname><given-names>M</given-names></name><etal/></person-group><article-title>Predictive value of insulin resistance surrogates for the development of diabetes in individuals with baseline normoglycemia: findings from two independent cohort studies in China and Japan</article-title><source>Diabetol Metab Syndr</source><year>2024</year><volume>16</volume><fpage>68</fpage><pub-id pub-id-type="doi">10.1186/s13098-024-01307-x</pub-id><pub-id pub-id-type="pmid">38491516</pub-id><pub-id pub-id-type="pmcid">PMC10943817</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Shangguan Q, Liu Q, Yang R, Zhang S, Sheng G, Kuang M, et al. Predictive value of insulin resistance surrogates for the development of diabetes in individuals with baseline normoglycemia: findings from two independent cohort studies in China and Japan. Diabetol Metab Syndr. 2024;16:68. 10.1186/s13098-024-01307-x.<pub-id pub-id-type="pmid">38491516</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13098-024-01307-x</pub-id><pub-id pub-id-type="pmcid">PMC10943817</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>EQ</given-names></name><name name-style="western"><surname>Weng</surname><given-names>YP</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>AM</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>CL</given-names></name></person-group><article-title>Association between triglyceride-glucose index and type 2 diabetes mellitus in the Japanese population: a secondary analysis of a retrospective cohort study</article-title><source>Biomed Res Int</source><year>2020</year><volume>2020</volume><fpage>2947067</fpage><pub-id pub-id-type="doi">10.1155/2020/2947067</pub-id><pub-id pub-id-type="pmid">33490240</pub-id><pub-id pub-id-type="pmcid">PMC7787715</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Liu EQ, Weng YP, Zhou AM, Zeng CL. Association between triglyceride-glucose index and type 2 diabetes mellitus in the Japanese population: a secondary analysis of a retrospective cohort study. Biomed Res Int. 2020;2020:2947067. 10.1155/2020/2947067.<pub-id pub-id-type="pmid">33490240</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2020/2947067</pub-id><pub-id pub-id-type="pmcid">PMC7787715</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name><name name-style="western"><surname>Yao</surname><given-names>T</given-names></name><name name-style="western"><surname>Lu</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T</given-names></name><etal/></person-group><article-title>Triglyceride glucose-body mass index and risk of incident type 2 diabetes mellitus in Japanese people with normal glycemic level: a population-based longitudinal cohort study</article-title><source>Front Endocrinol (Lausanne)</source><year>2022</year><volume>13</volume><fpage>907973</fpage><pub-id pub-id-type="doi">10.3389/fendo.2022.907973</pub-id><pub-id pub-id-type="pmid">35909552</pub-id><pub-id pub-id-type="pmcid">PMC9336540</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Song B, Zhao X, Yao T, Lu W, Zhang H, Liu T, et al. Triglyceride glucose-body mass index and risk of incident type 2 diabetes mellitus in Japanese people with normal glycemic level: a population-based longitudinal cohort study. Front Endocrinol (Lausanne). 2022;13: 907973. 10.3389/fendo.2022.907973.<pub-id pub-id-type="pmid">35909552</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fendo.2022.907973</pub-id><pub-id pub-id-type="pmcid">PMC9336540</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamagishi</surname><given-names>K</given-names></name><name name-style="western"><surname>Iso</surname><given-names>H</given-names></name></person-group><article-title>The criteria for metabolic syndrome and the national health screening and education system in Japan</article-title><source>Epidemiol Health</source><year>2017</year><volume>39</volume><fpage>e2017003</fpage><pub-id pub-id-type="doi">10.4178/epih.e2017003</pub-id><pub-id pub-id-type="pmid">28092931</pub-id><pub-id pub-id-type="pmcid">PMC5343105</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Yamagishi K, Iso H. The criteria for metabolic syndrome and the national health screening and education system in Japan. Epidemiol Health. 2017;39: e2017003. 10.4178/epih.e2017003.<pub-id pub-id-type="pmid">28092931</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4178/epih.e2017003</pub-id><pub-id pub-id-type="pmcid">PMC5343105</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="other">Health Promotion Center. Report of Fukushima Health Database (2021). 2021.</mixed-citation></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Araki</surname><given-names>E</given-names></name><name name-style="western"><surname>Goto</surname><given-names>A</given-names></name><name name-style="western"><surname>Kondo</surname><given-names>T</given-names></name><name name-style="western"><surname>Noda</surname><given-names>M</given-names></name><name name-style="western"><surname>Noto</surname><given-names>H</given-names></name><name name-style="western"><surname>Origasa</surname><given-names>H</given-names></name><etal/></person-group><article-title>Japanese clinical practice guideline for diabetes 2019</article-title><source>J Diabetes Investig</source><year>2020</year><volume>11</volume><fpage>1020</fpage><lpage>1076</lpage><pub-id pub-id-type="doi">10.1111/jdi.13306</pub-id><pub-id pub-id-type="pmid">33021749</pub-id><pub-id pub-id-type="pmcid">PMC7378414</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, et al. Japanese clinical practice guideline for diabetes 2019. J Diabetes Investig. 2020;11:1020&#8211;76. 10.1111/jdi.13306.<pub-id pub-id-type="pmid">33021749</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jdi.13306</pub-id><pub-id pub-id-type="pmcid">PMC7378414</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yasunaga</surname><given-names>H</given-names></name></person-group><article-title>The diagnosis procedure combination database</article-title><source>Ann Clin Epidemiol</source><year>2019</year><volume>1</volume><fpage>4</fpage><pub-id pub-id-type="doi">10.37737/ace.1.3_76</pub-id><pub-id pub-id-type="pmcid">PMC11668689</pub-id><pub-id pub-id-type="pmid">39726797</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Yasunaga H. The diagnosis procedure combination database. Ann Clin Epidemiol. 2019;1:4.<pub-id pub-id-type="doi" assigning-authority="pmc">10.37737/ace.24015</pub-id><pub-id pub-id-type="pmcid">PMC11668689</pub-id><pub-id pub-id-type="pmid">39726797</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohira</surname><given-names>T</given-names></name><name name-style="western"><surname>Nakano</surname><given-names>H</given-names></name><name name-style="western"><surname>Nagai</surname><given-names>M</given-names></name><name name-style="western"><surname>Yumiya</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Uemura</surname><given-names>M</given-names></name><etal/></person-group><article-title>Changes in cardiovascular risk factors after the great East Japan earthquake</article-title><source>Asia Pac J Public Health</source><year>2017</year><volume>29</volume><fpage>47S</fpage><lpage>55S</lpage><pub-id pub-id-type="doi">10.1177/1010539517695436</pub-id><pub-id pub-id-type="pmid">28330394</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Ohira T, Nakano H, Nagai M, Yumiya Y, Zhang W, Uemura M, et al. Changes in cardiovascular risk factors after the great East Japan earthquake. Asia Pac J Public Health. 2017;29:47S-55S. 10.1177/1010539517695436.<pub-id pub-id-type="pmid">28330394</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1010539517695436</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>E</given-names></name><name name-style="western"><surname>Fukasawa</surname><given-names>M</given-names></name><name name-style="western"><surname>Ohira</surname><given-names>T</given-names></name><name name-style="western"><surname>Yasumura</surname><given-names>S</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name><name name-style="western"><surname>Furuyama</surname><given-names>A</given-names></name><etal/></person-group><article-title>Lifestyle behaviour patterns in the prevention of type 2 diabetes mellitus: the Fukushima Health Database 2015&#8211;2020</article-title><source>Public Health</source><year>2023</year><volume>224</volume><fpage>98</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1016/j.puhe.2023.08.026</pub-id><pub-id pub-id-type="pmid">37742586</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Ma E, Fukasawa M, Ohira T, Yasumura S, Suzuki T, Furuyama A, et al. Lifestyle behaviour patterns in the prevention of type 2 diabetes mellitus: the Fukushima Health Database 2015&#8211;2020. Public Health. 2023;224:98&#8211;105. 10.1016/j.puhe.2023.08.026.<pub-id pub-id-type="pmid">37742586</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.puhe.2023.08.026</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>E</given-names></name><name name-style="western"><surname>Ohira</surname><given-names>T</given-names></name><name name-style="western"><surname>Fukasawa</surname><given-names>M</given-names></name><name name-style="western"><surname>Yasumura</surname><given-names>S</given-names></name><name name-style="western"><surname>Miyazaki</surname><given-names>M</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name><etal/></person-group><article-title>Prevalence trends of metabolic syndrome in residents of postdisaster Fukushima: a longitudinal analysis of Fukushima Health Database 2012&#8211;2019</article-title><source>Public Health</source><year>2023</year><volume>217</volume><fpage>115</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1016/j.puhe.2023.01.036</pub-id><pub-id pub-id-type="pmid">36878120</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Ma E, Ohira T, Fukasawa M, Yasumura S, Miyazaki M, Suzuki T, et al. Prevalence trends of metabolic syndrome in residents of postdisaster Fukushima: a longitudinal analysis of Fukushima Health Database 2012&#8211;2019. Public Health. 2023;217:115&#8211;24. 10.1016/j.puhe.2023.01.036.<pub-id pub-id-type="pmid">36878120</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.puhe.2023.01.036</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohira</surname><given-names>T</given-names></name><name name-style="western"><surname>Nakano</surname><given-names>H</given-names></name><name name-style="western"><surname>Okazaki</surname><given-names>K</given-names></name><name name-style="western"><surname>Hayashi</surname><given-names>F</given-names></name><name name-style="western"><surname>Nagao</surname><given-names>M</given-names></name><name name-style="western"><surname>Sakai</surname><given-names>A</given-names></name><etal/></person-group><article-title>Trends in lifestyle-related diseases and their risk factors after the Fukushima Daiichi nuclear power plant accident: results of the comprehensive health check in the Fukushima health management survey</article-title><source>J Epidemiol</source><year>2022</year><volume>32</volume><fpage>S36</fpage><lpage>S46</lpage><pub-id pub-id-type="doi">10.2188/jea.JE20210386</pub-id><pub-id pub-id-type="pmid">36464299</pub-id><pub-id pub-id-type="pmcid">PMC9703921</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Ohira T, Nakano H, Okazaki K, Hayashi F, Nagao M, Sakai A, et al. Trends in lifestyle-related diseases and their risk factors after the Fukushima Daiichi nuclear power plant accident: results of the comprehensive health check in the Fukushima health management survey. J Epidemiol. 2022;32:S36&#8211;46. 10.2188/jea.JE20210386.<pub-id pub-id-type="pmid">36464299</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2188/jea.JE20210386</pub-id><pub-id pub-id-type="pmcid">PMC9703921</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brahimaj</surname><given-names>A</given-names></name><name name-style="western"><surname>Rivadeneira</surname><given-names>F</given-names></name><name name-style="western"><surname>Muka</surname><given-names>T</given-names></name><name name-style="western"><surname>Sijbrands</surname><given-names>EJG</given-names></name><name name-style="western"><surname>Franco</surname><given-names>OH</given-names></name><name name-style="western"><surname>Dehghan</surname><given-names>A</given-names></name><etal/></person-group><article-title>Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study</article-title><source>Diabetologia</source><year>2019</year><volume>62</volume><fpage>1581</fpage><lpage>1590</lpage><pub-id pub-id-type="doi">10.1007/s00125-019-4921-2</pub-id><pub-id pub-id-type="pmid">31183505</pub-id><pub-id pub-id-type="pmcid">PMC6677703</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Brahimaj A, Rivadeneira F, Muka T, Sijbrands EJG, Franco OH, Dehghan A, et al. Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study. Diabetologia. 2019;62:1581&#8211;90. 10.1007/s00125-019-4921-2.<pub-id pub-id-type="pmid">31183505</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00125-019-4921-2</pub-id><pub-id pub-id-type="pmcid">PMC6677703</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>JC</given-names></name><name name-style="western"><surname>Malik</surname><given-names>V</given-names></name><name name-style="western"><surname>Jia</surname><given-names>W</given-names></name><name name-style="western"><surname>Kadowaki</surname><given-names>T</given-names></name><name name-style="western"><surname>Yajnik</surname><given-names>CS</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>KH</given-names></name><etal/></person-group><article-title>Diabetes in Asia: epidemiology, risk factors, and pathophysiology</article-title><source>JAMA</source><year>2009</year><volume>301</volume><fpage>2129</fpage><lpage>2140</lpage><pub-id pub-id-type="doi">10.1001/jama.2009.726</pub-id><pub-id pub-id-type="pmid">19470990</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129&#8211;40. 10.1001/jama.2009.726.<pub-id pub-id-type="pmid">19470990</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2009.726</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ayundini</surname><given-names>G</given-names></name><name name-style="western"><surname>Astrella</surname><given-names>C</given-names></name><name name-style="western"><surname>Tahapary</surname><given-names>D</given-names></name><name name-style="western"><surname>Soewondo</surname><given-names>P</given-names></name></person-group><article-title>A systematic review on the association between lipid accumulation product index and type 2 diabetes mellitus</article-title><source>J ASEAN Fed Endocr Soc.</source><year>2019</year><volume>34</volume><fpage>16</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.15605/jafes.034.01.04</pub-id><pub-id pub-id-type="pmid">33442132</pub-id><pub-id pub-id-type="pmcid">PMC7784243</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Ayundini G, Astrella C, Tahapary D, Soewondo P. A systematic review on the association between lipid accumulation product index and type 2 diabetes mellitus. J ASEAN Fed Endocr Soc. 2019;34:16&#8211;20. 10.15605/jafes.034.01.04.<pub-id pub-id-type="pmid">33442132</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15605/jafes.034.01.04</pub-id><pub-id pub-id-type="pmcid">PMC7784243</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ashwell</surname><given-names>M</given-names></name><name name-style="western"><surname>Hsieh</surname><given-names>SD</given-names></name></person-group><article-title>Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity</article-title><source>Int J Food Sci Nutr</source><year>2005</year><volume>56</volume><fpage>303</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1080/09637480500195066</pub-id><pub-id pub-id-type="pmid">16236591</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Ashwell M, Hsieh SD. Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr. 2005;56:303&#8211;7. 10.1080/09637480500195066.<pub-id pub-id-type="pmid">16236591</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/09637480500195066</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wakabayashi</surname><given-names>I</given-names></name><name name-style="western"><surname>Daimon</surname><given-names>T</given-names></name></person-group><article-title>The, "cardiometabolic index" as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus</article-title><source>Clin Chim Acta</source><year>2015</year><volume>438</volume><fpage>274</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1016/j.cca.2014.08.042</pub-id><pub-id pub-id-type="pmid">25199852</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Wakabayashi I, Daimon T. The, &#8220;cardiometabolic index&#8221; as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus. Clin Chim Acta. 2015;438:274&#8211;8. 10.1016/j.cca.2014.08.042.<pub-id pub-id-type="pmid">25199852</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cca.2014.08.042</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mosad</surname><given-names>AS</given-names></name><name name-style="western"><surname>Elfadil</surname><given-names>GA</given-names></name><name name-style="western"><surname>Elhassan</surname><given-names>SH</given-names></name><name name-style="western"><surname>Elbashir</surname><given-names>ZA</given-names></name><name name-style="western"><surname>Husain</surname><given-names>NEOSA</given-names></name><name name-style="western"><surname>Karar</surname><given-names>T</given-names></name><etal/></person-group><article-title>Diagnostic performance using obesity and lipid-related indices and atherogenic index of plasma to predict metabolic syndrome in the adult sudanese population</article-title><source>Niger J Clin Pract</source><year>2023</year><volume>26</volume><fpage>617</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.4103/njcp.njcp_692_22</pub-id><pub-id pub-id-type="pmid">37357479</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Mosad AS, Elfadil GA, Elhassan SH, Elbashir ZA, Husain NEOSA, Karar T, et al. Diagnostic performance using obesity and lipid-related indices and atherogenic index of plasma to predict metabolic syndrome in the adult sudanese population. Niger J Clin Pract. 2023;26:617&#8211;24. 10.4103/njcp.njcp_692_22.<pub-id pub-id-type="pmid">37357479</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/njcp.njcp_692_22</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qiu</surname><given-names>J</given-names></name><name name-style="western"><surname>Kuang</surname><given-names>M</given-names></name><name name-style="western"><surname>Zou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>R</given-names></name><name name-style="western"><surname>Shangguan</surname><given-names>Q</given-names></name><name name-style="western"><surname>Liu</surname><given-names>D</given-names></name><etal/></person-group><article-title>The predictive significance of lipid accumulation products for future diabetes in a non-diabetic population from a gender perspective: an analysis using time-dependent receiver operating characteristics</article-title><source>Front Endocrinol (Lausanne)</source><year>2023</year><volume>14</volume><fpage>1285637</fpage><pub-id pub-id-type="doi">10.3389/fendo.2023.1285637</pub-id><pub-id pub-id-type="pmid">38034005</pub-id><pub-id pub-id-type="pmcid">PMC10682705</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Qiu J, Kuang M, Zou Y, Yang R, Shangguan Q, Liu D, et al. The predictive significance of lipid accumulation products for future diabetes in a non-diabetic population from a gender perspective: an analysis using time-dependent receiver operating characteristics. Front Endocrinol (Lausanne). 2023;14:1285637. 10.3389/fendo.2023.1285637.<pub-id pub-id-type="pmid">38034005</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fendo.2023.1285637</pub-id><pub-id pub-id-type="pmcid">PMC10682705</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zha</surname><given-names>F</given-names></name><name name-style="western"><surname>Cao</surname><given-names>C</given-names></name><name name-style="western"><surname>Hong</surname><given-names>M</given-names></name><name name-style="western"><surname>Hou</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Tang</surname><given-names>B</given-names></name><etal/></person-group><article-title>The nonlinear correlation between the cardiometabolic index and the risk of diabetes: a retrospective Japanese cohort study</article-title><source>Front Endocrinol (Lausanne)</source><year>2023</year><volume>14</volume><fpage>1120277</fpage><pub-id pub-id-type="doi">10.3389/fendo.2023.1120277</pub-id><pub-id pub-id-type="pmid">36875460</pub-id><pub-id pub-id-type="pmcid">PMC9980900</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Zha F, Cao C, Hong M, Hou H, Zhang Q, Tang B, et al. The nonlinear correlation between the cardiometabolic index and the risk of diabetes: a retrospective Japanese cohort study. Front Endocrinol (Lausanne). 2023;14:1120277. 10.3389/fendo.2023.1120277.<pub-id pub-id-type="pmid">36875460</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fendo.2023.1120277</pub-id><pub-id pub-id-type="pmcid">PMC9980900</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wakabayashi</surname><given-names>I</given-names></name></person-group><article-title>Relationship between alcohol intake and lipid accumulation product in middle-aged men</article-title><source>Alcohol Alcohol</source><year>2013</year><volume>48</volume><fpage>535</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.1093/alcalc/agt032</pub-id><pub-id pub-id-type="pmid">23592501</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Wakabayashi I. Relationship between alcohol intake and lipid accumulation product in middle-aged men. Alcohol Alcohol. 2013;48:535&#8211;42. 10.1093/alcalc/agt032.<pub-id pub-id-type="pmid">23592501</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/alcalc/agt032</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baek</surname><given-names>W</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JW</given-names></name><name name-style="western"><surname>Lee</surname><given-names>HS</given-names></name><name name-style="western"><surname>Han</surname><given-names>D</given-names></name><name name-style="western"><surname>Choi</surname><given-names>SY</given-names></name><name name-style="western"><surname>Chun</surname><given-names>EJ</given-names></name><etal/></person-group><article-title>Concurrent smoking and alcohol consumers had higher triglyceride glucose indices than either only smokers or alcohol consumers: a cross-sectional study in Korea</article-title><source>Lipids Health Dis</source><year>2021</year><volume>20</volume><fpage>49</fpage><pub-id pub-id-type="doi">10.1186/s12944-021-01472-2</pub-id><pub-id pub-id-type="pmid">33975592</pub-id><pub-id pub-id-type="pmcid">PMC8111749</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Baek W, Lee JW, Lee HS, Han D, Choi SY, Chun EJ, et al. Concurrent smoking and alcohol consumers had higher triglyceride glucose indices than either only smokers or alcohol consumers: a cross-sectional study in Korea. Lipids Health Dis. 2021;20:49. 10.1186/s12944-021-01472-2.<pub-id pub-id-type="pmid">33975592</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12944-021-01472-2</pub-id><pub-id pub-id-type="pmcid">PMC8111749</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burch</surname><given-names>PM</given-names></name><name name-style="western"><surname>Glaab</surname><given-names>WE</given-names></name><name name-style="western"><surname>Holder</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>JA</given-names></name><name name-style="western"><surname>Sauer</surname><given-names>JM</given-names></name><name name-style="western"><surname>Walker</surname><given-names>EG</given-names></name></person-group><article-title>Net reclassification index and integrated discrimination index are not appropriate for testing whether a biomarker improves predictive performance</article-title><source>Toxicol Sci</source><year>2017</year><volume>156</volume><fpage>11</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1093/toxsci/kfw225</pub-id><pub-id pub-id-type="pmid">27815493</pub-id><pub-id pub-id-type="pmcid">PMC5837334</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Burch PM, Glaab WE, Holder DJ, Phillips JA, Sauer JM, Walker EG. Net reclassification index and integrated discrimination index are not appropriate for testing whether a biomarker improves predictive performance. Toxicol Sci. 2017;156:11&#8211;3. 10.1093/toxsci/kfw225.<pub-id pub-id-type="pmid">27815493</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kfw225</pub-id><pub-id pub-id-type="pmcid">PMC5837334</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montaser</surname><given-names>E</given-names></name><name name-style="western"><surname>Farhy</surname><given-names>LS</given-names></name><name name-style="western"><surname>Kovatchev</surname><given-names>BP</given-names></name></person-group><article-title>Novel detection and progression markers for diabetes based on continuous glucose monitoring data dynamics</article-title><source>J Clin Endocrinol Metab</source><year>2024</year><volume>110</volume><fpage>254</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1210/clinem/dgae379</pub-id><pub-id pub-id-type="pmid">38820084</pub-id><pub-id pub-id-type="pmcid">PMC11651704</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Montaser E, Farhy LS, Kovatchev BP. Novel detection and progression markers for diabetes based on continuous glucose monitoring data dynamics. J Clin Endocrinol Metab. 2024;110:254&#8211;62. 10.1210/clinem/dgae379.<pub-id pub-id-type="pmid">38820084</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1210/clinem/dgae379</pub-id><pub-id pub-id-type="pmcid">PMC11651704</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montaser</surname><given-names>E</given-names></name><name name-style="western"><surname>Shah</surname><given-names>VN</given-names></name></person-group><article-title>Prediction of incident diabetic retinopathy in adults with type 1 diabetes using machine learning approach: an exploratory study</article-title><source>J Diabetes Sci Technol</source><year>2024</year><pub-id pub-id-type="doi">10.1177/19322968241292369</pub-id><pub-id pub-id-type="pmid">39465559</pub-id><pub-id pub-id-type="pmcid">PMC11571610</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Montaser E, Shah VN. Prediction of incident diabetic retinopathy in adults with type 1 diabetes using machine learning approach: an exploratory study. J Diabetes Sci Technol. 2024. 10.1177/19322968241292369.<pub-id pub-id-type="pmid">39465559</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/19322968241292369</pub-id><pub-id pub-id-type="pmcid">PMC11571610</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Habu</surname><given-names>M</given-names></name><name name-style="western"><surname>Okada</surname><given-names>H</given-names></name><name name-style="western"><surname>Hamaguchi</surname><given-names>M</given-names></name><name name-style="western"><surname>Kurogi</surname><given-names>K</given-names></name><name name-style="western"><surname>Murata</surname><given-names>H</given-names></name><name name-style="western"><surname>Ito</surname><given-names>M</given-names></name><etal/></person-group><article-title>Association between occupation type and development of type 2 diabetes: a population-based panasonic cohort study 3</article-title><source>Front Public Health</source><year>2023</year><volume>11</volume><fpage>1103275</fpage><pub-id pub-id-type="doi">10.3389/fpubh.2023.1103275</pub-id><pub-id pub-id-type="pmid">36741952</pub-id><pub-id pub-id-type="pmcid">PMC9893857</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Habu M, Okada H, Hamaguchi M, Kurogi K, Murata H, Ito M, et al. Association between occupation type and development of type 2 diabetes: a population-based panasonic cohort study 3. Front Public Health. 2023;11:1103275. 10.3389/fpubh.2023.1103275.<pub-id pub-id-type="pmid">36741952</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fpubh.2023.1103275</pub-id><pub-id pub-id-type="pmcid">PMC9893857</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>